| 
ENDOSOMAL VACUOLAR PATHWAY
 | 
10
 | 
2.26e-06
 | 
-0.863000
 | 
4.72e-05
 | 
| 
PROTEIN LIPOYLATION
 | 
10
 | 
6.85e-06
 | 
0.821000
 | 
1.28e-04
 | 
| 
COMPLEX III ASSEMBLY
 | 
17
 | 
1.00e-08
 | 
0.802000
 | 
3.48e-07
 | 
| 
BRANCHED CHAIN AMINO ACID CATABOLISM
 | 
20
 | 
2.75e-09
 | 
0.768000
 | 
1.07e-07
 | 
| 
COMPLEX I BIOGENESIS
 | 
58
 | 
5.14e-24
 | 
0.766000
 | 
9.26e-22
 | 
| 
MITOCHONDRIAL IRON SULFUR CLUSTER BIOGENESIS
 | 
10
 | 
3.06e-05
 | 
0.761000
 | 
4.37e-04
 | 
| 
MITOCHONDRIAL FATTY ACID BETA OXIDATION
 | 
33
 | 
2.01e-13
 | 
0.739000
 | 
1.51e-11
 | 
| 
RESPIRATORY ELECTRON TRANSPORT
 | 
124
 | 
2.20e-45
 | 
0.734000
 | 
6.61e-43
 | 
| 
CITRIC ACID CYCLE TCA CYCLE
 | 
33
 | 
6.56e-13
 | 
0.723000
 | 
4.22e-11
 | 
| 
MATURATION OF TCA ENZYMES AND REGULATION OF TCA CYCLE
 | 
18
 | 
1.34e-07
 | 
0.718000
 | 
4.30e-06
 | 
| 
BETA OXIDATION OF VERY LONG CHAIN FATTY ACIDS
 | 
11
 | 
5.73e-05
 | 
0.701000
 | 
7.73e-04
 | 
| 
CROSSLINKING OF COLLAGEN FIBRILS
 | 
18
 | 
6.88e-07
 | 
-0.676000
 | 
1.77e-05
 | 
| 
GLYOXYLATE METABOLISM AND GLYCINE DEGRADATION
 | 
14
 | 
1.21e-05
 | 
0.675000
 | 
2.02e-04
 | 
| 
MITOTIC TELOPHASE CYTOKINESIS
 | 
13
 | 
2.55e-05
 | 
-0.674000
 | 
3.76e-04
 | 
| 
MITOCHONDRIAL TRANSLATION
 | 
87
 | 
2.88e-27
 | 
0.670000
 | 
6.48e-25
 | 
| 
ESTABLISHMENT OF SISTER CHROMATID COHESION
 | 
10
 | 
3.34e-04
 | 
-0.655000
 | 
3.30e-03
 | 
| 
AEROBIC RESPIRATION AND RESPIRATORY ELECTRON TRANSPORT
 | 
202
 | 
8.16e-58
 | 
0.653000
 | 
3.67e-55
 | 
| 
HEME BIOSYNTHESIS
 | 
12
 | 
1.61e-04
 | 
0.629000
 | 
1.84e-03
 | 
| 
MITOCHONDRIAL PROTEIN DEGRADATION
 | 
70
 | 
9.87e-20
 | 
0.628000
 | 
1.27e-17
 | 
| 
COMPLEX IV ASSEMBLY
 | 
38
 | 
4.88e-11
 | 
0.616000
 | 
2.93e-09
 | 
| 
COHESIN LOADING ONTO CHROMATIN
 | 
10
 | 
8.86e-04
 | 
-0.607000
 | 
7.13e-03
 | 
| 
UBIQUINOL BIOSYNTHESIS
 | 
11
 | 
5.47e-04
 | 
0.602000
 | 
5.07e-03
 | 
| 
AFLATOXIN ACTIVATION AND DETOXIFICATION
 | 
10
 | 
9.84e-04
 | 
0.602000
 | 
7.70e-03
 | 
| 
REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX
 | 
14
 | 
1.14e-04
 | 
0.596000
 | 
1.35e-03
 | 
| 
TNFS BIND THEIR PHYSIOLOGICAL RECEPTORS
 | 
11
 | 
6.94e-04
 | 
-0.591000
 | 
5.95e-03
 | 
| 
ASPIRIN ADME
 | 
17
 | 
3.89e-05
 | 
0.576000
 | 
5.39e-04
 | 
| 
ER PHAGOSOME PATHWAY
 | 
19
 | 
2.38e-05
 | 
-0.560000
 | 
3.56e-04
 | 
| 
CHOLESTEROL BIOSYNTHESIS
 | 
26
 | 
1.74e-06
 | 
0.542000
 | 
3.90e-05
 | 
| 
NON INTEGRIN MEMBRANE ECM INTERACTIONS
 | 
30
 | 
4.18e-07
 | 
-0.534000
 | 
1.14e-05
 | 
| 
DEGRADATION OF CYSTEINE AND HOMOCYSTEINE
 | 
10
 | 
4.10e-03
 | 
0.524000
 | 
2.26e-02
 | 
| 
BIOTIN TRANSPORT AND METABOLISM
 | 
11
 | 
3.05e-03
 | 
0.516000
 | 
1.79e-02
 | 
| 
INFLAMMASOMES
 | 
12
 | 
2.09e-03
 | 
-0.513000
 | 
1.36e-02
 | 
| 
ACYL CHAIN REMODELLING OF PE
 | 
15
 | 
6.17e-04
 | 
0.511000
 | 
5.49e-03
 | 
| 
LYSINE CATABOLISM
 | 
10
 | 
5.50e-03
 | 
0.507000
 | 
2.75e-02
 | 
| 
SULFUR AMINO ACID METABOLISM
 | 
19
 | 
1.42e-04
 | 
0.504000
 | 
1.66e-03
 | 
| 
PEROXISOMAL LIPID METABOLISM
 | 
27
 | 
6.66e-06
 | 
0.501000
 | 
1.28e-04
 | 
| 
MET ACTIVATES PTK2 SIGNALING
 | 
18
 | 
4.14e-04
 | 
-0.481000
 | 
3.96e-03
 | 
| 
CHONDROITIN SULFATE BIOSYNTHESIS
 | 
16
 | 
9.57e-04
 | 
-0.477000
 | 
7.55e-03
 | 
| 
SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL
 | 
14
 | 
2.02e-03
 | 
0.477000
 | 
1.33e-02
 | 
| 
SYNDECAN INTERACTIONS
 | 
14
 | 
2.02e-03
 | 
-0.476000
 | 
1.33e-02
 | 
| 
TP53 REGULATES TRANSCRIPTION OF CELL CYCLE GENES
 | 
30
 | 
7.30e-06
 | 
-0.473000
 | 
1.34e-04
 | 
| 
ACTIVATION OF THE PRE REPLICATIVE COMPLEX
 | 
31
 | 
5.32e-06
 | 
-0.472000
 | 
1.04e-04
 | 
| 
COLLAGEN CHAIN TRIMERIZATION
 | 
34
 | 
1.93e-06
 | 
-0.472000
 | 
4.24e-05
 | 
| 
ABC TRANSPORTERS IN LIPID HOMEOSTASIS
 | 
14
 | 
2.43e-03
 | 
0.468000
 | 
1.51e-02
 | 
| 
NCAM1 INTERACTIONS
 | 
16
 | 
1.28e-03
 | 
-0.465000
 | 
9.62e-03
 | 
| 
COLLAGEN BIOSYNTHESIS AND MODIFYING ENZYMES
 | 
53
 | 
6.11e-09
 | 
-0.462000
 | 
2.29e-07
 | 
| 
MITOCHONDRIAL BIOGENESIS
 | 
10
 | 
1.25e-02
 | 
0.456000
 | 
5.38e-02
 | 
| 
TRANSCRIPTIONAL ACTIVATION OF MITOCHONDRIAL BIOGENESIS
 | 
10
 | 
1.25e-02
 | 
0.456000
 | 
5.38e-02
 | 
| 
PEROXISOMAL PROTEIN IMPORT
 | 
61
 | 
8.93e-10
 | 
0.454000
 | 
4.14e-08
 | 
| 
CONDENSATION OF PROPHASE CHROMOSOMES
 | 
12
 | 
7.17e-03
 | 
-0.448000
 | 
3.41e-02
 | 
| 
BIOSYNTHESIS OF SPECIALIZED PRORESOLVING MEDIATORS SPMS
 | 
12
 | 
7.65e-03
 | 
0.445000
 | 
3.57e-02
 | 
| 
NUCLEOTIDE BIOSYNTHESIS
 | 
12
 | 
8.15e-03
 | 
0.441000
 | 
3.74e-02
 | 
| 
GLUTATHIONE CONJUGATION
 | 
32
 | 
1.58e-05
 | 
0.441000
 | 
2.47e-04
 | 
| 
ASSEMBLY OF COLLAGEN FIBRILS AND OTHER MULTIMERIC STRUCTURES
 | 
42
 | 
8.07e-07
 | 
-0.440000
 | 
2.02e-05
 | 
| 
TRANSCRIPTIONAL REGULATION BY E2F6
 | 
23
 | 
2.60e-04
 | 
-0.440000
 | 
2.63e-03
 | 
| 
COLLAGEN FORMATION
 | 
65
 | 
9.21e-10
 | 
-0.439000
 | 
4.14e-08
 | 
| 
METABOLISM OF PORPHYRINS
 | 
21
 | 
5.07e-04
 | 
0.438000
 | 
4.75e-03
 | 
| 
PRC2 METHYLATES HISTONES AND DNA
 | 
15
 | 
3.41e-03
 | 
-0.437000
 | 
1.94e-02
 | 
| 
RUNX3 REGULATES NOTCH SIGNALING
 | 
10
 | 
1.72e-02
 | 
-0.435000
 | 
6.90e-02
 | 
| 
RHO GTPASES ACTIVATE WASPS AND WAVES
 | 
33
 | 
2.10e-05
 | 
-0.428000
 | 
3.20e-04
 | 
| 
ACTIVATION OF ATR IN RESPONSE TO REPLICATION STRESS
 | 
34
 | 
1.59e-05
 | 
-0.428000
 | 
2.47e-04
 | 
| 
ECM PROTEOGLYCANS
 | 
35
 | 
1.36e-05
 | 
-0.425000
 | 
2.21e-04
 | 
| 
PECAM1 INTERACTIONS
 | 
11
 | 
1.54e-02
 | 
-0.422000
 | 
6.27e-02
 | 
| 
ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC
 | 
26
 | 
2.42e-04
 | 
-0.416000
 | 
2.51e-03
 | 
| 
IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL
 | 
52
 | 
2.25e-07
 | 
-0.415000
 | 
6.87e-06
 | 
| 
INTEGRIN CELL SURFACE INTERACTIONS
 | 
65
 | 
7.40e-09
 | 
-0.415000
 | 
2.67e-07
 | 
| 
REGULATION OF KIT SIGNALING
 | 
12
 | 
1.30e-02
 | 
-0.414000
 | 
5.47e-02
 | 
| 
AMINE LIGAND BINDING RECEPTORS
 | 
14
 | 
7.64e-03
 | 
0.412000
 | 
3.57e-02
 | 
| 
FATTY ACID METABOLISM
 | 
133
 | 
3.10e-16
 | 
0.410000
 | 
3.48e-14
 | 
| 
GLUCONEOGENESIS
 | 
19
 | 
1.99e-03
 | 
0.410000
 | 
1.33e-02
 | 
| 
METABOLISM OF COFACTORS
 | 
23
 | 
7.14e-04
 | 
0.408000
 | 
6.06e-03
 | 
| 
MET PROMOTES CELL MOTILITY
 | 
28
 | 
2.45e-04
 | 
-0.400000
 | 
2.51e-03
 | 
| 
GENERATION OF SECOND MESSENGER MOLECULES
 | 
12
 | 
1.74e-02
 | 
-0.396000
 | 
6.98e-02
 | 
| 
LAMININ INTERACTIONS
 | 
15
 | 
7.89e-03
 | 
-0.396000
 | 
3.66e-02
 | 
| 
ACYL CHAIN REMODELLING OF PC
 | 
17
 | 
4.77e-03
 | 
0.395000
 | 
2.49e-02
 | 
| 
TP53 REGULATES TRANSCRIPTION OF ADDITIONAL CELL CYCLE GENES WHOSE EXACT ROLE IN THE P53 PATHWAY REMAIN UNCERTAIN
 | 
16
 | 
6.26e-03
 | 
-0.395000
 | 
3.04e-02
 | 
| 
TNF RECEPTOR SUPERFAMILY TNFSF MEMBERS MEDIATING NON CANONICAL NF KB PATHWAY
 | 
11
 | 
2.45e-02
 | 
-0.392000
 | 
9.10e-02
 | 
| 
TRANSLATION
 | 
218
 | 
3.14e-23
 | 
0.390000
 | 
4.70e-21
 | 
| 
PYRUVATE METABOLISM
 | 
42
 | 
1.38e-05
 | 
0.388000
 | 
2.21e-04
 | 
| 
HSF1 DEPENDENT TRANSACTIVATION
 | 
23
 | 
1.31e-03
 | 
0.387000
 | 
9.64e-03
 | 
| 
POLYMERASE SWITCHING
 | 
14
 | 
1.25e-02
 | 
-0.386000
 | 
5.38e-02
 | 
| 
DAP12 INTERACTIONS
 | 
31
 | 
2.45e-04
 | 
-0.381000
 | 
2.51e-03
 | 
| 
LAGGING STRAND SYNTHESIS
 | 
20
 | 
3.26e-03
 | 
-0.380000
 | 
1.90e-02
 | 
| 
ELASTIC FIBRE FORMATION
 | 
36
 | 
8.43e-05
 | 
-0.379000
 | 
1.04e-03
 | 
| 
PROTEIN LOCALIZATION
 | 
95
 | 
1.94e-10
 | 
0.378000
 | 
1.09e-08
 | 
| 
DNA STRAND ELONGATION
 | 
24
 | 
1.55e-03
 | 
-0.373000
 | 
1.08e-02
 | 
| 
CHK1 CHK2 CDS1 MEDIATED INACTIVATION OF CYCLIN B CDK1 COMPLEX
 | 
10
 | 
4.15e-02
 | 
-0.372000
 | 
1.35e-01
 | 
| 
METABOLISM OF STEROID HORMONES
 | 
15
 | 
1.28e-02
 | 
0.371000
 | 
5.43e-02
 | 
| 
PROCESSIVE SYNTHESIS ON THE LAGGING STRAND
 | 
15
 | 
1.36e-02
 | 
-0.368000
 | 
5.65e-02
 | 
| 
NCAM SIGNALING FOR NEURITE OUT GROWTH
 | 
34
 | 
2.20e-04
 | 
-0.366000
 | 
2.33e-03
 | 
| 
COBALAMIN CBL VITAMIN B12 TRANSPORT AND METABOLISM
 | 
13
 | 
2.35e-02
 | 
0.363000
 | 
8.86e-02
 | 
| 
PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS
 | 
10
 | 
4.77e-02
 | 
-0.362000
 | 
1.49e-01
 | 
| 
G0 AND EARLY G1
 | 
16
 | 
1.31e-02
 | 
-0.358000
 | 
5.47e-02
 | 
| 
TRANSLESION SYNTHESIS BY Y FAMILY DNA POLYMERASES BYPASSES LESIONS ON DNA TEMPLATE
 | 
37
 | 
1.82e-04
 | 
-0.356000
 | 
2.02e-03
 | 
| 
SYNTHESIS OF LEUKOTRIENES LT AND EOXINS EX
 | 
11
 | 
4.19e-02
 | 
0.354000
 | 
1.36e-01
 | 
| 
TRANSLESION SYNTHESIS BY POLK
 | 
17
 | 
1.27e-02
 | 
-0.349000
 | 
5.41e-02
 | 
| 
LGI ADAM INTERACTIONS
 | 
10
 | 
5.61e-02
 | 
0.349000
 | 
1.67e-01
 | 
| 
INTERLEUKIN 4 AND INTERLEUKIN 13 SIGNALING
 | 
10
 | 
5.68e-02
 | 
-0.348000
 | 
1.68e-01
 | 
| 
PARACETAMOL ADME
 | 
20
 | 
7.53e-03
 | 
0.345000
 | 
3.55e-02
 | 
| 
DNA DAMAGE TELOMERE STRESS INDUCED SENESCENCE
 | 
26
 | 
2.33e-03
 | 
-0.345000
 | 
1.47e-02
 | 
| 
ENERGY DEPENDENT REGULATION OF MTOR BY LKB1 AMPK
 | 
29
 | 
1.31e-03
 | 
0.345000
 | 
9.64e-03
 | 
| 
MOLECULES ASSOCIATED WITH ELASTIC FIBRES
 | 
29
 | 
1.32e-03
 | 
-0.345000
 | 
9.68e-03
 | 
| 
EXTRACELLULAR MATRIX ORGANIZATION
 | 
191
 | 
4.41e-16
 | 
-0.341000
 | 
4.41e-14
 | 
| 
METABOLISM OF ANGIOTENSINOGEN TO ANGIOTENSINS
 | 
11
 | 
5.02e-02
 | 
0.341000
 | 
1.54e-01
 | 
| 
VITAMIN B5 PANTOTHENATE METABOLISM
 | 
14
 | 
2.77e-02
 | 
0.340000
 | 
1.00e-01
 | 
| 
ALPHA LINOLENIC OMEGA3 AND LINOLEIC OMEGA6 ACID METABOLISM
 | 
11
 | 
5.25e-02
 | 
0.338000
 | 
1.60e-01
 | 
| 
DEADENYLATION OF MRNA
 | 
22
 | 
6.17e-03
 | 
-0.337000
 | 
3.02e-02
 | 
| 
TELOMERE C STRAND LAGGING STRAND SYNTHESIS
 | 
31
 | 
1.17e-03
 | 
-0.337000
 | 
8.93e-03
 | 
| 
METABOLISM OF STEROIDS
 | 
80
 | 
2.29e-07
 | 
0.335000
 | 
6.87e-06
 | 
| 
AKT PHOSPHORYLATES TARGETS IN THE CYTOSOL
 | 
11
 | 
5.53e-02
 | 
-0.334000
 | 
1.66e-01
 | 
| 
HOMOLOGOUS DNA PAIRING AND STRAND EXCHANGE
 | 
23
 | 
5.64e-03
 | 
-0.333000
 | 
2.79e-02
 | 
| 
TERMINATION OF TRANSLESION DNA SYNTHESIS
 | 
31
 | 
1.38e-03
 | 
-0.332000
 | 
9.94e-03
 | 
| 
CASPASE ACTIVATION VIA EXTRINSIC APOPTOTIC SIGNALLING PATHWAY
 | 
17
 | 
1.79e-02
 | 
-0.332000
 | 
7.08e-02
 | 
| 
CELLULAR HEXOSE TRANSPORT
 | 
13
 | 
3.96e-02
 | 
0.330000
 | 
1.31e-01
 | 
| 
REGULATION OF ENDOGENOUS RETROELEMENTS
 | 
28
 | 
2.79e-03
 | 
-0.327000
 | 
1.66e-02
 | 
| 
RAC2 GTPASE CYCLE
 | 
80
 | 
4.57e-07
 | 
-0.326000
 | 
1.21e-05
 | 
| 
SYNTHESIS OF PIPS AT THE LATE ENDOSOME MEMBRANE
 | 
10
 | 
7.42e-02
 | 
-0.326000
 | 
2.01e-01
 | 
| 
INTERFERON ALPHA BETA SIGNALING
 | 
19
 | 
1.39e-02
 | 
-0.326000
 | 
5.76e-02
 | 
| 
FLT3 SIGNALING
 | 
26
 | 
4.56e-03
 | 
-0.321000
 | 
2.45e-02
 | 
| 
PINK1 PRKN MEDIATED MITOPHAGY
 | 
30
 | 
2.35e-03
 | 
0.321000
 | 
1.47e-02
 | 
| 
MITOPHAGY
 | 
37
 | 
7.39e-04
 | 
0.321000
 | 
6.11e-03
 | 
| 
CRMPS IN SEMA3A SIGNALING
 | 
14
 | 
3.79e-02
 | 
-0.320000
 | 
1.27e-01
 | 
| 
PROCESSIVE SYNTHESIS ON THE C STRAND OF THE TELOMERE
 | 
18
 | 
1.95e-02
 | 
-0.318000
 | 
7.58e-02
 | 
| 
DNA DAMAGE BYPASS
 | 
46
 | 
2.00e-04
 | 
-0.317000
 | 
2.19e-03
 | 
| 
RAC3 GTPASE CYCLE
 | 
82
 | 
8.69e-07
 | 
-0.314000
 | 
2.08e-05
 | 
| 
O LINKED GLYCOSYLATION OF MUCINS
 | 
30
 | 
2.99e-03
 | 
-0.313000
 | 
1.77e-02
 | 
| 
COLLAGEN DEGRADATION
 | 
39
 | 
7.35e-04
 | 
-0.312000
 | 
6.11e-03
 | 
| 
SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE
 | 
15
 | 
3.80e-02
 | 
-0.309000
 | 
1.27e-01
 | 
| 
MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE
 | 
12
 | 
6.43e-02
 | 
0.309000
 | 
1.82e-01
 | 
| 
REGULATION OF PYRUVATE METABOLISM
 | 
32
 | 
2.59e-03
 | 
0.308000
 | 
1.57e-02
 | 
| 
METABOLISM OF AMINO ACIDS AND DERIVATIVES
 | 
187
 | 
4.64e-13
 | 
0.307000
 | 
3.21e-11
 | 
| 
GLYCEROPHOSPHOLIPID BIOSYNTHESIS
 | 
86
 | 
8.78e-07
 | 
0.307000
 | 
2.08e-05
 | 
| 
MITOCHONDRIAL CALCIUM ION TRANSPORT
 | 
14
 | 
4.77e-02
 | 
0.306000
 | 
1.49e-01
 | 
| 
OVARIAN TUMOR DOMAIN PROTEASES
 | 
31
 | 
3.36e-03
 | 
-0.304000
 | 
1.93e-02
 | 
| 
CARNITINE METABOLISM
 | 
14
 | 
4.92e-02
 | 
0.304000
 | 
1.52e-01
 | 
| 
METAL ION SLC TRANSPORTERS
 | 
17
 | 
3.17e-02
 | 
-0.301000
 | 
1.11e-01
 | 
| 
POLYMERASE SWITCHING ON THE C STRAND OF THE TELOMERE
 | 
23
 | 
1.27e-02
 | 
-0.300000
 | 
5.41e-02
 | 
| 
SIGNALING BY RETINOIC ACID
 | 
34
 | 
2.50e-03
 | 
0.300000
 | 
1.54e-02
 | 
| 
SYNTHESIS OF BILE ACIDS AND BILE SALTS
 | 
24
 | 
1.16e-02
 | 
0.298000
 | 
5.10e-02
 | 
| 
CYTOPROTECTION BY HMOX1
 | 
44
 | 
6.49e-04
 | 
0.297000
 | 
5.67e-03
 | 
| 
RESOLUTION OF D LOOP STRUCTURES
 | 
29
 | 
5.63e-03
 | 
-0.297000
 | 
2.79e-02
 | 
| 
FCGAMMA RECEPTOR FCGR DEPENDENT PHAGOCYTOSIS
 | 
74
 | 
1.05e-05
 | 
-0.296000
 | 
1.78e-04
 | 
| 
METABOLISM OF NITRIC OXIDE NOS3 ACTIVATION AND REGULATION
 | 
15
 | 
4.73e-02
 | 
-0.296000
 | 
1.49e-01
 | 
| 
FORMATION OF SENESCENCE ASSOCIATED HETEROCHROMATIN FOCI SAHF
 | 
10
 | 
1.07e-01
 | 
-0.294000
 | 
2.66e-01
 | 
| 
RHOU GTPASE CYCLE
 | 
38
 | 
1.73e-03
 | 
-0.294000
 | 
1.19e-02
 | 
| 
REGULATION OF NF KAPPA B SIGNALING
 | 
16
 | 
4.31e-02
 | 
-0.292000
 | 
1.39e-01
 | 
| 
TRP CHANNELS
 | 
15
 | 
5.02e-02
 | 
-0.292000
 | 
1.54e-01
 | 
| 
RHOV GTPASE CYCLE
 | 
34
 | 
3.34e-03
 | 
-0.291000
 | 
1.93e-02
 | 
| 
NEGATIVE REGULATION OF FLT3
 | 
13
 | 
7.10e-02
 | 
-0.289000
 | 
1.96e-01
 | 
| 
SIGNALING BY HIPPO
 | 
20
 | 
2.52e-02
 | 
-0.289000
 | 
9.29e-02
 | 
| 
VXPX CARGO TARGETING TO CILIUM
 | 
17
 | 
3.94e-02
 | 
-0.289000
 | 
1.31e-01
 | 
| 
DETOXIFICATION OF REACTIVE OXYGEN SPECIES
 | 
30
 | 
6.33e-03
 | 
0.288000
 | 
3.04e-02
 | 
| 
KERATAN SULFATE BIOSYNTHESIS
 | 
21
 | 
2.35e-02
 | 
-0.286000
 | 
8.86e-02
 | 
| 
EPHB MEDIATED FORWARD SIGNALING
 | 
35
 | 
3.81e-03
 | 
-0.283000
 | 
2.14e-02
 | 
| 
NONSENSE MEDIATED DECAY NMD INDEPENDENT OF THE EXON JUNCTION COMPLEX EJC
 | 
88
 | 
4.80e-06
 | 
0.282000
 | 
9.59e-05
 | 
| 
SIGNALING BY BMP
 | 
23
 | 
1.92e-02
 | 
-0.282000
 | 
7.49e-02
 | 
| 
FCGR ACTIVATION
 | 
11
 | 
1.06e-01
 | 
-0.282000
 | 
2.65e-01
 | 
| 
VOLTAGE GATED POTASSIUM CHANNELS
 | 
21
 | 
2.54e-02
 | 
0.282000
 | 
9.32e-02
 | 
| 
RAC1 GTPASE CYCLE
 | 
162
 | 
6.76e-10
 | 
-0.281000
 | 
3.38e-08
 | 
| 
ISG15 ANTIVIRAL MECHANISM
 | 
27
 | 
1.16e-02
 | 
-0.281000
 | 
5.10e-02
 | 
| 
PHASE II CONJUGATION OF COMPOUNDS
 | 
69
 | 
6.07e-05
 | 
0.279000
 | 
8.00e-04
 | 
| 
HDR THROUGH SINGLE STRAND ANNEALING SSA
 | 
34
 | 
5.19e-03
 | 
-0.277000
 | 
2.64e-02
 | 
| 
STRIATED MUSCLE CONTRACTION
 | 
29
 | 
9.99e-03
 | 
0.276000
 | 
4.49e-02
 | 
| 
CHONDROITIN SULFATE DERMATAN SULFATE METABOLISM
 | 
40
 | 
2.55e-03
 | 
-0.276000
 | 
1.55e-02
 | 
| 
FOXO MEDIATED TRANSCRIPTION
 | 
20
 | 
3.30e-02
 | 
-0.275000
 | 
1.14e-01
 | 
| 
TELOMERE C STRAND SYNTHESIS INITIATION
 | 
11
 | 
1.14e-01
 | 
-0.275000
 | 
2.79e-01
 | 
| 
TELOMERE MAINTENANCE
 | 
47
 | 
1.15e-03
 | 
-0.274000
 | 
8.85e-03
 | 
| 
IL 6 TYPE CYTOKINE RECEPTOR LIGAND INTERACTIONS
 | 
11
 | 
1.16e-01
 | 
-0.274000
 | 
2.81e-01
 | 
| 
HDR THROUGH HOMOLOGOUS RECOMBINATION HRR
 | 
53
 | 
6.05e-04
 | 
-0.272000
 | 
5.44e-03
 | 
| 
G BETA GAMMA SIGNALLING THROUGH CDC42
 | 
15
 | 
6.81e-02
 | 
-0.272000
 | 
1.90e-01
 | 
| 
HDR THROUGH MMEJ ALT NHEJ
 | 
12
 | 
1.03e-01
 | 
-0.272000
 | 
2.61e-01
 | 
| 
TP53 REGULATES METABOLIC GENES
 | 
66
 | 
1.44e-04
 | 
0.271000
 | 
1.67e-03
 | 
| 
TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION
 | 
14
 | 
7.98e-02
 | 
-0.270000
 | 
2.14e-01
 | 
| 
N GLYCAN ANTENNAE ELONGATION
 | 
13
 | 
9.59e-02
 | 
-0.267000
 | 
2.47e-01
 | 
| 
GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTEGRINS
 | 
14
 | 
8.46e-02
 | 
-0.266000
 | 
2.24e-01
 | 
| 
UNBLOCKING OF NMDA RECEPTORS GLUTAMATE BINDING AND ACTIVATION
 | 
16
 | 
6.65e-02
 | 
0.265000
 | 
1.88e-01
 | 
| 
RND3 GTPASE CYCLE
 | 
36
 | 
5.96e-03
 | 
-0.265000
 | 
2.93e-02
 | 
| 
MAP3K8 TPL2 DEPENDENT MAPK1 3 ACTIVATION
 | 
12
 | 
1.14e-01
 | 
-0.263000
 | 
2.79e-01
 | 
| 
RECEPTOR MEDIATED MITOPHAGY
 | 
11
 | 
1.31e-01
 | 
0.263000
 | 
3.02e-01
 | 
| 
GLYCOGEN METABOLISM
 | 
17
 | 
6.10e-02
 | 
0.262000
 | 
1.75e-01
 | 
| 
SYNTHESIS OF IP2 IP AND INS IN THE CYTOSOL
 | 
12
 | 
1.17e-01
 | 
0.262000
 | 
2.81e-01
 | 
| 
CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS
 | 
12
 | 
1.18e-01
 | 
-0.261000
 | 
2.84e-01
 | 
| 
TNFR1 INDUCED PROAPOPTOTIC SIGNALING
 | 
22
 | 
3.46e-02
 | 
-0.260000
 | 
1.18e-01
 | 
| 
ENOS ACTIVATION
 | 
12
 | 
1.19e-01
 | 
-0.260000
 | 
2.85e-01
 | 
| 
SYNTHESIS OF PA
 | 
25
 | 
2.44e-02
 | 
0.260000
 | 
9.10e-02
 | 
| 
SIGNALING BY PDGF
 | 
50
 | 
1.49e-03
 | 
-0.260000
 | 
1.06e-02
 | 
| 
DEACTIVATION OF THE BETA CATENIN TRANSACTIVATING COMPLEX
 | 
29
 | 
1.59e-02
 | 
-0.259000
 | 
6.46e-02
 | 
| 
SHC MEDIATED CASCADE FGFR3
 | 
11
 | 
1.37e-01
 | 
-0.259000
 | 
3.12e-01
 | 
| 
METABOLISM
 | 
1435
 | 
1.19e-58
 | 
0.257000
 | 
1.07e-55
 | 
| 
TRANSLESION SYNTHESIS BY POLH
 | 
18
 | 
5.87e-02
 | 
-0.257000
 | 
1.72e-01
 | 
| 
THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS
 | 
24
 | 
2.97e-02
 | 
-0.256000
 | 
1.05e-01
 | 
| 
ACTIVATION OF SMO
 | 
10
 | 
1.60e-01
 | 
-0.256000
 | 
3.47e-01
 | 
| 
MISMATCH REPAIR
 | 
14
 | 
9.83e-02
 | 
-0.255000
 | 
2.51e-01
 | 
| 
CHROMOSOME MAINTENANCE
 | 
66
 | 
3.44e-04
 | 
-0.255000
 | 
3.36e-03
 | 
| 
G2 M DNA DAMAGE CHECKPOINT
 | 
52
 | 
1.52e-03
 | 
-0.254000
 | 
1.07e-02
 | 
| 
BILE ACID AND BILE SALT METABOLISM
 | 
28
 | 
1.99e-02
 | 
0.254000
 | 
7.70e-02
 | 
| 
P75NTR SIGNALS VIA NF KB
 | 
16
 | 
7.94e-02
 | 
-0.253000
 | 
2.13e-01
 | 
| 
CASPASE ACTIVATION VIA DEATH RECEPTORS IN THE PRESENCE OF LIGAND
 | 
14
 | 
1.02e-01
 | 
-0.252000
 | 
2.60e-01
 | 
| 
CDC42 GTPASE CYCLE
 | 
90
 | 
3.53e-05
 | 
-0.252000
 | 
4.97e-04
 | 
| 
DRUG ADME
 | 
63
 | 
5.55e-04
 | 
0.252000
 | 
5.10e-03
 | 
| 
REGULATION OF TP53 ACTIVITY THROUGH METHYLATION
 | 
17
 | 
7.33e-02
 | 
-0.251000
 | 
2.00e-01
 | 
| 
PROCESSING OF DNA DOUBLE STRAND BREAK ENDS
 | 
56
 | 
1.21e-03
 | 
-0.250000
 | 
9.17e-03
 | 
| 
AMINO ACIDS REGULATE MTORC1
 | 
46
 | 
3.63e-03
 | 
0.248000
 | 
2.05e-02
 | 
| 
PENTOSE PHOSPHATE PATHWAY
 | 
14
 | 
1.08e-01
 | 
0.248000
 | 
2.67e-01
 | 
| 
CLASS B 2 SECRETIN FAMILY RECEPTORS
 | 
28
 | 
2.33e-02
 | 
-0.248000
 | 
8.84e-02
 | 
| 
GLUTATHIONE SYNTHESIS AND RECYCLING
 | 
11
 | 
1.58e-01
 | 
0.246000
 | 
3.43e-01
 | 
| 
EXTENSION OF TELOMERES
 | 
43
 | 
5.26e-03
 | 
-0.246000
 | 
2.66e-02
 | 
| 
SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION
 | 
25
 | 
3.34e-02
 | 
-0.246000
 | 
1.15e-01
 | 
| 
NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS
 | 
42
 | 
6.30e-03
 | 
-0.244000
 | 
3.04e-02
 | 
| 
HEME DEGRADATION
 | 
10
 | 
1.83e-01
 | 
0.243000
 | 
3.79e-01
 | 
| 
P75NTR RECRUITS SIGNALLING COMPLEXES
 | 
13
 | 
1.29e-01
 | 
-0.243000
 | 
2.99e-01
 | 
| 
HOMOLOGY DIRECTED REPAIR
 | 
93
 | 
5.75e-05
 | 
-0.242000
 | 
7.73e-04
 | 
| 
GLYCOGEN BREAKDOWN GLYCOGENOLYSIS
 | 
13
 | 
1.33e-01
 | 
0.241000
 | 
3.05e-01
 | 
| 
REGULATION OF TP53 ACTIVITY THROUGH ACETYLATION
 | 
28
 | 
2.80e-02
 | 
-0.240000
 | 
1.01e-01
 | 
| 
G PROTEIN BETA GAMMA SIGNALLING
 | 
27
 | 
3.19e-02
 | 
-0.239000
 | 
1.11e-01
 | 
| 
TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS
 | 
37
 | 
1.22e-02
 | 
-0.238000
 | 
5.30e-02
 | 
| 
BBSOME MEDIATED CARGO TARGETING TO CILIUM
 | 
11
 | 
1.71e-01
 | 
-0.238000
 | 
3.62e-01
 | 
| 
G BETA GAMMA SIGNALLING THROUGH PI3KGAMMA
 | 
20
 | 
6.75e-02
 | 
-0.236000
 | 
1.89e-01
 | 
| 
P130CAS LINKAGE TO MAPK SIGNALING FOR INTEGRINS
 | 
14
 | 
1.28e-01
 | 
-0.235000
 | 
2.99e-01
 | 
| 
RHOD GTPASE CYCLE
 | 
49
 | 
4.57e-03
 | 
-0.234000
 | 
2.45e-02
 | 
| 
DOWNSTREAM SIGNALING OF ACTIVATED FGFR3
 | 
18
 | 
8.63e-02
 | 
-0.234000
 | 
2.28e-01
 | 
| 
DOWNREGULATION OF TGF BETA RECEPTOR SIGNALING
 | 
16
 | 
1.06e-01
 | 
-0.233000
 | 
2.65e-01
 | 
| 
RHOF GTPASE CYCLE
 | 
39
 | 
1.21e-02
 | 
-0.232000
 | 
5.28e-02
 | 
| 
NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY
 | 
40
 | 
1.11e-02
 | 
0.232000
 | 
4.99e-02
 | 
| 
PROCESSING OF INTRONLESS PRE MRNAS
 | 
20
 | 
7.27e-02
 | 
-0.232000
 | 
1.99e-01
 | 
| 
PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR
 | 
14
 | 
1.34e-01
 | 
-0.231000
 | 
3.07e-01
 | 
| 
TRANSFERRIN ENDOCYTOSIS AND RECYCLING
 | 
25
 | 
4.67e-02
 | 
0.230000
 | 
1.48e-01
 | 
| 
BIOLOGICAL OXIDATIONS
 | 
130
 | 
7.44e-06
 | 
0.228000
 | 
1.34e-04
 | 
| 
INTRINSIC PATHWAY FOR APOPTOSIS
 | 
34
 | 
2.25e-02
 | 
-0.226000
 | 
8.59e-02
 | 
| 
GPER1 SIGNALING
 | 
22
 | 
6.69e-02
 | 
-0.226000
 | 
1.89e-01
 | 
| 
REDUCTION OF CYTOSOLIC CA LEVELS
 | 
12
 | 
1.76e-01
 | 
-0.225000
 | 
3.71e-01
 | 
| 
RIPK1 MEDIATED REGULATED NECROSIS
 | 
29
 | 
3.59e-02
 | 
-0.225000
 | 
1.22e-01
 | 
| 
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 12
 | 
16
 | 
1.20e-01
 | 
-0.224000
 | 
2.87e-01
 | 
| 
FATTY ACYL COA BIOSYNTHESIS
 | 
26
 | 
4.82e-02
 | 
0.224000
 | 
1.50e-01
 | 
| 
AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE
 | 
23
 | 
6.37e-02
 | 
0.223000
 | 
1.82e-01
 | 
| 
G PROTEIN ACTIVATION
 | 
15
 | 
1.36e-01
 | 
-0.222000
 | 
3.09e-01
 | 
| 
RHOB GTPASE CYCLE
 | 
65
 | 
1.96e-03
 | 
-0.222000
 | 
1.32e-02
 | 
| 
REGULATION OF LOCALIZATION OF FOXO TRANSCRIPTION FACTORS
 | 
12
 | 
1.83e-01
 | 
-0.222000
 | 
3.79e-01
 | 
| 
GAP FILLING DNA REPAIR SYNTHESIS AND LIGATION IN GG NER
 | 
22
 | 
7.17e-02
 | 
-0.222000
 | 
1.97e-01
 | 
| 
SIGNALING BY TGF BETA RECEPTOR COMPLEX
 | 
73
 | 
1.06e-03
 | 
-0.222000
 | 
8.22e-03
 | 
| 
SUMOYLATION OF IMMUNE RESPONSE PROTEINS
 | 
11
 | 
2.04e-01
 | 
-0.221000
 | 
4.05e-01
 | 
| 
ARACHIDONIC ACID METABOLISM
 | 
33
 | 
2.85e-02
 | 
0.220000
 | 
1.02e-01
 | 
| 
CA DEPENDENT EVENTS
 | 
25
 | 
5.67e-02
 | 
-0.220000
 | 
1.68e-01
 | 
| 
RHOC GTPASE CYCLE
 | 
65
 | 
2.24e-03
 | 
-0.219000
 | 
1.42e-02
 | 
| 
MUSCLE CONTRACTION
 | 
126
 | 
2.61e-05
 | 
0.217000
 | 
3.79e-04
 | 
| 
PI 3K CASCADE FGFR3
 | 
12
 | 
1.93e-01
 | 
-0.217000
 | 
3.95e-01
 | 
| 
S PHASE
 | 
140
 | 
1.01e-05
 | 
-0.216000
 | 
1.75e-04
 | 
| 
METABOLISM OF LIPIDS
 | 
463
 | 
2.08e-15
 | 
0.216000
 | 
1.70e-13
 | 
| 
AURKA ACTIVATION BY TPX2
 | 
68
 | 
2.08e-03
 | 
-0.216000
 | 
1.35e-02
 | 
| 
ACYL CHAIN REMODELLING OF PS
 | 
14
 | 
1.62e-01
 | 
0.216000
 | 
3.49e-01
 | 
| 
GLUCAGON TYPE LIGAND RECEPTORS
 | 
17
 | 
1.24e-01
 | 
-0.215000
 | 
2.94e-01
 | 
| 
GPVI MEDIATED ACTIVATION CASCADE
 | 
29
 | 
4.49e-02
 | 
-0.215000
 | 
1.43e-01
 | 
| 
TETRAHYDROBIOPTERIN BH4 SYNTHESIS RECYCLING SALVAGE AND REGULATION
 | 
10
 | 
2.39e-01
 | 
0.215000
 | 
4.50e-01
 | 
| 
CLASS I PEROXISOMAL MEMBRANE PROTEIN IMPORT
 | 
18
 | 
1.15e-01
 | 
0.215000
 | 
2.80e-01
 | 
| 
ROLE OF PHOSPHOLIPIDS IN PHAGOCYTOSIS
 | 
19
 | 
1.05e-01
 | 
-0.215000
 | 
2.65e-01
 | 
| 
ACYL CHAIN REMODELLING OF PG
 | 
10
 | 
2.40e-01
 | 
0.214000
 | 
4.50e-01
 | 
| 
RHO GTPASES ACTIVATE KTN1
 | 
10
 | 
2.41e-01
 | 
-0.214000
 | 
4.50e-01
 | 
| 
HDMS DEMETHYLATE HISTONES
 | 
21
 | 
8.99e-02
 | 
-0.214000
 | 
2.35e-01
 | 
| 
SUMOYLATION OF TRANSCRIPTION COFACTORS
 | 
37
 | 
2.46e-02
 | 
-0.214000
 | 
9.11e-02
 | 
| 
SIGNALING BY MET
 | 
61
 | 
4.24e-03
 | 
-0.212000
 | 
2.33e-02
 | 
| 
SUMOYLATION OF DNA DAMAGE RESPONSE AND REPAIR PROTEINS
 | 
72
 | 
1.96e-03
 | 
-0.211000
 | 
1.32e-02
 | 
| 
ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS
 | 
10
 | 
2.51e-01
 | 
0.210000
 | 
4.59e-01
 | 
| 
HDACS DEACETYLATE HISTONES
 | 
29
 | 
5.13e-02
 | 
-0.209000
 | 
1.57e-01
 | 
| 
G2 M CHECKPOINTS
 | 
121
 | 
7.61e-05
 | 
-0.208000
 | 
9.51e-04
 | 
| 
CELL CYCLE
 | 
508
 | 
1.20e-15
 | 
-0.208000
 | 
1.08e-13
 | 
| 
PLATELET CALCIUM HOMEOSTASIS
 | 
22
 | 
9.21e-02
 | 
-0.208000
 | 
2.39e-01
 | 
| 
NONSENSE MEDIATED DECAY NMD
 | 
107
 | 
2.18e-04
 | 
0.207000
 | 
2.33e-03
 | 
| 
DOPAMINE NEUROTRANSMITTER RELEASE CYCLE
 | 
15
 | 
1.67e-01
 | 
-0.206000
 | 
3.57e-01
 | 
| 
DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE
 | 
19
 | 
1.20e-01
 | 
-0.206000
 | 
2.87e-01
 | 
| 
MISMATCH REPAIR MMR DIRECTED BY MSH2 MSH3 MUTSBETA
 | 
10
 | 
2.60e-01
 | 
-0.206000
 | 
4.68e-01
 | 
| 
MITOTIC G1 PHASE AND G1 S TRANSITION
 | 
126
 | 
7.11e-05
 | 
-0.205000
 | 
9.14e-04
 | 
| 
PROTEIN HYDROXYLATION
 | 
16
 | 
1.56e-01
 | 
0.205000
 | 
3.41e-01
 | 
| 
RHOQ GTPASE CYCLE
 | 
56
 | 
8.14e-03
 | 
-0.205000
 | 
3.74e-02
 | 
| 
ION HOMEOSTASIS
 | 
45
 | 
1.82e-02
 | 
0.204000
 | 
7.14e-02
 | 
| 
APOPTOTIC CLEAVAGE OF CELLULAR PROTEINS
 | 
34
 | 
4.07e-02
 | 
-0.203000
 | 
1.34e-01
 | 
| 
ANCHORING OF THE BASAL BODY TO THE PLASMA MEMBRANE
 | 
92
 | 
8.03e-04
 | 
-0.202000
 | 
6.57e-03
 | 
| 
CYTOCHROME C MEDIATED APOPTOTIC RESPONSE
 | 
11
 | 
2.46e-01
 | 
-0.202000
 | 
4.54e-01
 | 
| 
SHC1 EVENTS IN ERBB4 SIGNALING
 | 
10
 | 
2.70e-01
 | 
-0.201000
 | 
4.81e-01
 | 
| 
INTERLEUKIN 6 FAMILY SIGNALING
 | 
16
 | 
1.65e-01
 | 
-0.201000
 | 
3.53e-01
 | 
| 
CARDIAC CONDUCTION
 | 
76
 | 
2.52e-03
 | 
0.201000
 | 
1.54e-02
 | 
| 
RESOLUTION OF SISTER CHROMATID COHESION
 | 
102
 | 
4.90e-04
 | 
-0.200000
 | 
4.64e-03
 | 
| 
TRANSCRIPTIONAL ACTIVITY OF SMAD2 SMAD3 SMAD4 HETEROTRIMER
 | 
39
 | 
3.14e-02
 | 
-0.199000
 | 
1.10e-01
 | 
| 
ACTIVATION OF BAD AND TRANSLOCATION TO MITOCHONDRIA
 | 
12
 | 
2.32e-01
 | 
-0.199000
 | 
4.44e-01
 | 
| 
APOPTOTIC EXECUTION PHASE
 | 
42
 | 
2.56e-02
 | 
-0.199000
 | 
9.34e-02
 | 
| 
PRESYNAPTIC FUNCTION OF KAINATE RECEPTORS
 | 
16
 | 
1.69e-01
 | 
-0.199000
 | 
3.59e-01
 | 
| 
MITOTIC PROMETAPHASE
 | 
171
 | 
7.58e-06
 | 
-0.199000
 | 
1.34e-04
 | 
| 
EUKARYOTIC TRANSLATION INITIATION
 | 
112
 | 
2.98e-04
 | 
0.198000
 | 
2.98e-03
 | 
| 
CARGO TRAFFICKING TO THE PERICILIARY MEMBRANE
 | 
34
 | 
4.77e-02
 | 
-0.196000
 | 
1.49e-01
 | 
| 
APOPTOTIC FACTOR MEDIATED RESPONSE
 | 
14
 | 
2.05e-01
 | 
-0.196000
 | 
4.05e-01
 | 
| 
DEGRADATION OF THE EXTRACELLULAR MATRIX
 | 
79
 | 
2.71e-03
 | 
-0.195000
 | 
1.63e-02
 | 
| 
RHO GTPASES ACTIVATE NADPH OXIDASES
 | 
18
 | 
1.52e-01
 | 
-0.195000
 | 
3.35e-01
 | 
| 
EPIGENETIC REGULATION OF GENE EXPRESSION
 | 
103
 | 
6.81e-04
 | 
-0.194000
 | 
5.89e-03
 | 
| 
A TETRASACCHARIDE LINKER SEQUENCE IS REQUIRED FOR GAG SYNTHESIS
 | 
19
 | 
1.44e-01
 | 
-0.194000
 | 
3.22e-01
 | 
| 
DOWNSTREAM SIGNALING OF ACTIVATED FGFR2
 | 
19
 | 
1.45e-01
 | 
-0.193000
 | 
3.22e-01
 | 
| 
SHC MEDIATED CASCADE FGFR2
 | 
12
 | 
2.47e-01
 | 
-0.193000
 | 
4.55e-01
 | 
| 
PCNA DEPENDENT LONG PATCH BASE EXCISION REPAIR
 | 
21
 | 
1.26e-01
 | 
-0.193000
 | 
2.97e-01
 | 
| 
RHOG GTPASE CYCLE
 | 
67
 | 
6.72e-03
 | 
-0.192000
 | 
3.22e-02
 | 
| 
PKMTS METHYLATE HISTONE LYSINES
 | 
36
 | 
4.68e-02
 | 
-0.192000
 | 
1.48e-01
 | 
| 
PROTEIN METHYLATION
 | 
17
 | 
1.72e-01
 | 
0.191000
 | 
3.63e-01
 | 
| 
TNFR1 INDUCED NF KAPPA B SIGNALING PATHWAY
 | 
32
 | 
6.12e-02
 | 
-0.191000
 | 
1.75e-01
 | 
| 
CYCLIN D ASSOCIATED EVENTS IN G1
 | 
41
 | 
3.44e-02
 | 
-0.191000
 | 
1.18e-01
 | 
| 
RESOLUTION OF AP SITES VIA THE MULTIPLE NUCLEOTIDE PATCH REPLACEMENT PATHWAY
 | 
24
 | 
1.05e-01
 | 
-0.191000
 | 
2.65e-01
 | 
| 
PLASMA LIPOPROTEIN ASSEMBLY
 | 
13
 | 
2.34e-01
 | 
0.191000
 | 
4.46e-01
 | 
| 
PLASMA LIPOPROTEIN REMODELING
 | 
19
 | 
1.51e-01
 | 
0.190000
 | 
3.33e-01
 | 
| 
RAF INDEPENDENT MAPK1 3 ACTIVATION
 | 
20
 | 
1.41e-01
 | 
-0.190000
 | 
3.18e-01
 | 
| 
SLBP DEPENDENT PROCESSING OF REPLICATION DEPENDENT HISTONE PRE MRNAS
 | 
10
 | 
2.98e-01
 | 
0.190000
 | 
5.10e-01
 | 
| 
RHOA GTPASE CYCLE
 | 
132
 | 
1.70e-04
 | 
-0.190000
 | 
1.92e-03
 | 
| 
N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI
 | 
20
 | 
1.42e-01
 | 
-0.190000
 | 
3.19e-01
 | 
| 
METABOLISM OF WATER SOLUBLE VITAMINS AND COFACTORS
 | 
104
 | 
8.88e-04
 | 
0.189000
 | 
7.13e-03
 | 
| 
RND1 GTPASE CYCLE
 | 
38
 | 
4.52e-02
 | 
-0.188000
 | 
1.44e-01
 | 
| 
SEMA4D INDUCED CELL MIGRATION AND GROWTH CONE COLLAPSE
 | 
11
 | 
2.82e-01
 | 
0.187000
 | 
4.92e-01
 | 
| 
DOWNSTREAM SIGNALING OF ACTIVATED FGFR4
 | 
18
 | 
1.70e-01
 | 
-0.187000
 | 
3.61e-01
 | 
| 
VEGFR2 MEDIATED VASCULAR PERMEABILITY
 | 
29
 | 
8.20e-02
 | 
-0.187000
 | 
2.19e-01
 | 
| 
NUCLEAR SIGNALING BY ERBB4
 | 
11
 | 
2.84e-01
 | 
0.187000
 | 
4.93e-01
 | 
| 
CELL CYCLE CHECKPOINTS
 | 
226
 | 
1.47e-06
 | 
-0.186000
 | 
3.40e-05
 | 
| 
ELEVATION OF CYTOSOLIC CA2 LEVELS
 | 
10
 | 
3.09e-01
 | 
-0.186000
 | 
5.23e-01
 | 
| 
DNA DOUBLE STRAND BREAK REPAIR
 | 
123
 | 
3.93e-04
 | 
-0.185000
 | 
3.81e-03
 | 
| 
SIGNALING BY VEGF
 | 
98
 | 
1.56e-03
 | 
-0.185000
 | 
1.08e-02
 | 
| 
SEMA3A PAK DEPENDENT AXON REPULSION
 | 
14
 | 
2.31e-01
 | 
-0.185000
 | 
4.42e-01
 | 
| 
P75 NTR RECEPTOR MEDIATED SIGNALLING
 | 
79
 | 
4.71e-03
 | 
-0.184000
 | 
2.48e-02
 | 
| 
G1 S TRANSITION
 | 
101
 | 
1.43e-03
 | 
-0.184000
 | 
1.02e-02
 | 
| 
RHO GTPASE EFFECTORS
 | 
217
 | 
3.32e-06
 | 
-0.184000
 | 
6.78e-05
 | 
| 
ACTIVATION OF BH3 ONLY PROTEINS
 | 
17
 | 
1.92e-01
 | 
-0.183000
 | 
3.92e-01
 | 
| 
NUCLEOTIDE LIKE PURINERGIC RECEPTORS
 | 
10
 | 
3.17e-01
 | 
0.183000
 | 
5.31e-01
 | 
| 
THROMBOXANE SIGNALLING THROUGH TP RECEPTOR
 | 
18
 | 
1.80e-01
 | 
-0.183000
 | 
3.76e-01
 | 
| 
SHC MEDIATED CASCADE FGFR4
 | 
11
 | 
2.96e-01
 | 
-0.182000
 | 
5.08e-01
 | 
| 
NRAGE SIGNALS DEATH THROUGH JNK
 | 
49
 | 
2.78e-02
 | 
-0.182000
 | 
1.00e-01
 | 
| 
ENDOGENOUS STEROLS
 | 
17
 | 
1.95e-01
 | 
0.181000
 | 
3.97e-01
 | 
| 
OTHER INTERLEUKIN SIGNALING
 | 
14
 | 
2.40e-01
 | 
-0.181000
 | 
4.50e-01
 | 
| 
SIGNALING BY TGFB FAMILY MEMBERS
 | 
105
 | 
1.34e-03
 | 
-0.181000
 | 
9.70e-03
 | 
| 
METALLOPROTEASE DUBS
 | 
17
 | 
1.97e-01
 | 
-0.181000
 | 
3.99e-01
 | 
| 
NETRIN 1 SIGNALING
 | 
12
 | 
2.78e-01
 | 
-0.181000
 | 
4.88e-01
 | 
| 
METABOLISM OF VITAMINS AND COFACTORS
 | 
157
 | 
9.88e-05
 | 
0.180000
 | 
1.20e-03
 | 
| 
REGULATED NECROSIS
 | 
45
 | 
3.65e-02
 | 
-0.180000
 | 
1.24e-01
 | 
| 
RECOGNITION OF DNA DAMAGE BY PCNA CONTAINING REPLICATION COMPLEX
 | 
30
 | 
8.77e-02
 | 
-0.180000
 | 
2.31e-01
 | 
| 
REGULATION OF PLK1 ACTIVITY AT G2 M TRANSITION
 | 
80
 | 
5.39e-03
 | 
-0.180000
 | 
2.71e-02
 | 
| 
SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE
 | 
49
 | 
2.95e-02
 | 
-0.180000
 | 
1.05e-01
 | 
| 
GLYCOSAMINOGLYCAN METABOLISM
 | 
98
 | 
2.13e-03
 | 
-0.180000
 | 
1.37e-02
 | 
| 
RHO GTPASE CYCLE
 | 
390
 | 
1.56e-09
 | 
-0.179000
 | 
6.69e-08
 | 
| 
TAK1 DEPENDENT IKK AND NF KAPPA B ACTIVATION
 | 
36
 | 
6.42e-02
 | 
-0.178000
 | 
1.82e-01
 | 
| 
SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS
 | 
17
 | 
2.04e-01
 | 
0.178000
 | 
4.05e-01
 | 
| 
KERATAN SULFATE KERATIN METABOLISM
 | 
28
 | 
1.04e-01
 | 
-0.178000
 | 
2.63e-01
 | 
| 
SIGNAL TRANSDUCTION BY L1
 | 
19
 | 
1.80e-01
 | 
-0.178000
 | 
3.76e-01
 | 
| 
DAP12 SIGNALING
 | 
21
 | 
1.59e-01
 | 
-0.177000
 | 
3.45e-01
 | 
| 
INTERLEUKIN 7 SIGNALING
 | 
12
 | 
2.87e-01
 | 
-0.177000
 | 
4.98e-01
 | 
| 
CELL SURFACE INTERACTIONS AT THE VASCULAR WALL
 | 
86
 | 
4.64e-03
 | 
-0.177000
 | 
2.46e-02
 | 
| 
SIGNALING BY TGFBR3
 | 
21
 | 
1.63e-01
 | 
-0.176000
 | 
3.50e-01
 | 
| 
CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE
 | 
28
 | 
1.08e-01
 | 
0.175000
 | 
2.67e-01
 | 
| 
EXTRA NUCLEAR ESTROGEN SIGNALING
 | 
60
 | 
1.90e-02
 | 
-0.175000
 | 
7.43e-02
 | 
| 
APOPTOSIS
 | 
89
 | 
4.34e-03
 | 
-0.175000
 | 
2.37e-02
 | 
| 
PROLONGED ERK ACTIVATION EVENTS
 | 
13
 | 
2.75e-01
 | 
-0.175000
 | 
4.84e-01
 | 
| 
DARPP 32 EVENTS
 | 
15
 | 
2.41e-01
 | 
0.175000
 | 
4.50e-01
 | 
| 
TRANSPORT OF INORGANIC CATIONS ANIONS AND AMINO ACIDS OLIGOPEPTIDES
 | 
79
 | 
7.26e-03
 | 
0.175000
 | 
3.44e-02
 | 
| 
NF KB IS ACTIVATED AND SIGNALS SURVIVAL
 | 
13
 | 
2.76e-01
 | 
-0.175000
 | 
4.84e-01
 | 
| 
CD209 DC SIGN SIGNALING
 | 
16
 | 
2.28e-01
 | 
-0.174000
 | 
4.39e-01
 | 
| 
RA BIOSYNTHESIS PATHWAY
 | 
15
 | 
2.44e-01
 | 
0.174000
 | 
4.52e-01
 | 
| 
SIGNALING BY FGFR3
 | 
32
 | 
8.91e-02
 | 
-0.174000
 | 
2.34e-01
 | 
| 
ONCOGENE INDUCED SENESCENCE
 | 
16
 | 
2.30e-01
 | 
-0.173000
 | 
4.41e-01
 | 
| 
EPHRIN SIGNALING
 | 
18
 | 
2.05e-01
 | 
-0.173000
 | 
4.05e-01
 | 
| 
SEMA4D IN SEMAPHORIN SIGNALING
 | 
15
 | 
2.47e-01
 | 
0.173000
 | 
4.55e-01
 | 
| 
PI METABOLISM
 | 
72
 | 
1.15e-02
 | 
-0.172000
 | 
5.10e-02
 | 
| 
EPH EPHRIN SIGNALING
 | 
57
 | 
2.55e-02
 | 
-0.171000
 | 
9.32e-02
 | 
| 
ALPHA PROTEIN KINASE 1 SIGNALING PATHWAY
 | 
11
 | 
3.28e-01
 | 
-0.171000
 | 
5.46e-01
 | 
| 
AMPLIFICATION OF SIGNAL FROM THE KINETOCHORES
 | 
79
 | 
9.11e-03
 | 
-0.170000
 | 
4.14e-02
 | 
| 
ADRENALINE NORADRENALINE INHIBITS INSULIN SECRETION
 | 
17
 | 
2.26e-01
 | 
-0.170000
 | 
4.38e-01
 | 
| 
SUMOYLATION OF DNA REPLICATION PROTEINS
 | 
41
 | 
6.04e-02
 | 
-0.170000
 | 
1.74e-01
 | 
| 
SIGNALING BY SCF KIT
 | 
33
 | 
9.33e-02
 | 
-0.169000
 | 
2.41e-01
 | 
| 
TRANSCRIPTIONAL REGULATION BY THE AP 2 TFAP2 FAMILY OF TRANSCRIPTION FACTORS
 | 
14
 | 
2.78e-01
 | 
-0.168000
 | 
4.87e-01
 | 
| 
POSITIVE EPIGENETIC REGULATION OF RRNA EXPRESSION
 | 
27
 | 
1.32e-01
 | 
-0.167000
 | 
3.05e-01
 | 
| 
ANTIGEN ACTIVATES B CELL RECEPTOR BCR LEADING TO GENERATION OF SECOND MESSENGERS
 | 
20
 | 
1.95e-01
 | 
-0.167000
 | 
3.97e-01
 | 
| 
ANTIGEN PROCESSING CROSS PRESENTATION
 | 
72
 | 
1.44e-02
 | 
-0.167000
 | 
5.94e-02
 | 
| 
NICOTINAMIDE SALVAGING
 | 
15
 | 
2.65e-01
 | 
-0.166000
 | 
4.73e-01
 | 
| 
SUMOYLATION
 | 
144
 | 
5.88e-04
 | 
-0.166000
 | 
5.34e-03
 | 
| 
RECRUITMENT OF NUMA TO MITOTIC CENTROSOMES
 | 
83
 | 
9.30e-03
 | 
-0.165000
 | 
4.20e-02
 | 
| 
G PROTEIN MEDIATED EVENTS
 | 
36
 | 
9.16e-02
 | 
-0.163000
 | 
2.38e-01
 | 
| 
DOWNREGULATION OF SMAD2 3 SMAD4 TRANSCRIPTIONAL ACTIVITY
 | 
23
 | 
1.79e-01
 | 
-0.162000
 | 
3.75e-01
 | 
| 
NEGATIVE REGULATION OF MET ACTIVITY
 | 
20
 | 
2.11e-01
 | 
-0.162000
 | 
4.12e-01
 | 
| 
MTOR SIGNALLING
 | 
41
 | 
7.35e-02
 | 
0.162000
 | 
2.00e-01
 | 
| 
CYTOSOLIC SENSORS OF PATHOGEN ASSOCIATED DNA
 | 
30
 | 
1.26e-01
 | 
-0.161000
 | 
2.97e-01
 | 
| 
DNA REPLICATION
 | 
121
 | 
2.21e-03
 | 
-0.161000
 | 
1.41e-02
 | 
| 
PLATELET SENSITIZATION BY LDL
 | 
16
 | 
2.65e-01
 | 
0.161000
 | 
4.73e-01
 | 
| 
PI 3K CASCADE FGFR2
 | 
13
 | 
3.20e-01
 | 
-0.159000
 | 
5.35e-01
 | 
| 
POTASSIUM CHANNELS
 | 
56
 | 
3.93e-02
 | 
0.159000
 | 
1.31e-01
 | 
| 
SIGNALING BY PTK6
 | 
44
 | 
6.94e-02
 | 
-0.158000
 | 
1.93e-01
 | 
| 
RETROGRADE NEUROTROPHIN SIGNALLING
 | 
10
 | 
3.87e-01
 | 
0.158000
 | 
6.05e-01
 | 
| 
INTERLEUKIN RECEPTOR SHC SIGNALING
 | 
17
 | 
2.60e-01
 | 
-0.158000
 | 
4.68e-01
 | 
| 
SMOOTH MUSCLE CONTRACTION
 | 
29
 | 
1.46e-01
 | 
0.156000
 | 
3.24e-01
 | 
| 
SIGNALING BY RHO GTPASES MIRO GTPASES AND RHOBTB3
 | 
564
 | 
3.65e-10
 | 
-0.155000
 | 
1.93e-08
 | 
| 
MAJOR PATHWAY OF RRNA PROCESSING IN THE NUCLEOLUS AND CYTOSOL
 | 
164
 | 
6.22e-04
 | 
0.155000
 | 
5.49e-03
 | 
| 
CD28 CO STIMULATION
 | 
31
 | 
1.36e-01
 | 
-0.155000
 | 
3.09e-01
 | 
| 
FCERI MEDIATED CA 2 MOBILIZATION
 | 
23
 | 
1.99e-01
 | 
-0.155000
 | 
4.01e-01
 | 
| 
PROGRAMMED CELL DEATH
 | 
117
 | 
3.99e-03
 | 
-0.154000
 | 
2.21e-02
 | 
| 
IRON UPTAKE AND TRANSPORT
 | 
46
 | 
7.15e-02
 | 
0.154000
 | 
1.97e-01
 | 
| 
SIGNALING BY TYPE 1 INSULIN LIKE GROWTH FACTOR 1 RECEPTOR IGF1R
 | 
33
 | 
1.27e-01
 | 
-0.154000
 | 
2.97e-01
 | 
| 
GRB2 EVENTS IN ERBB2 SIGNALING
 | 
10
 | 
4.01e-01
 | 
-0.153000
 | 
6.14e-01
 | 
| 
ERYTHROPOIETIN ACTIVATES PHOSPHOINOSITIDE 3 KINASE PI3K
 | 
11
 | 
3.78e-01
 | 
-0.153000
 | 
6.00e-01
 | 
| 
ACTIVATION OF THE MRNA UPON BINDING OF THE CAP BINDING COMPLEX AND EIFS AND SUBSEQUENT BINDING TO 43S
 | 
58
 | 
4.43e-02
 | 
0.153000
 | 
1.43e-01
 | 
| 
RHO GTPASES ACTIVATE FORMINS
 | 
116
 | 
5.04e-03
 | 
-0.151000
 | 
2.61e-02
 | 
| 
MACROAUTOPHAGY
 | 
119
 | 
4.58e-03
 | 
0.151000
 | 
2.45e-02
 | 
| 
SHC MEDIATED CASCADE FGFR1
 | 
11
 | 
3.88e-01
 | 
-0.150000
 | 
6.05e-01
 | 
| 
CYCLIN A B1 B2 ASSOCIATED EVENTS DURING G2 M TRANSITION
 | 
22
 | 
2.22e-01
 | 
-0.150000
 | 
4.33e-01
 | 
| 
CELL CELL COMMUNICATION
 | 
70
 | 
2.98e-02
 | 
-0.150000
 | 
1.05e-01
 | 
| 
SYNTHESIS OF PE
 | 
10
 | 
4.12e-01
 | 
0.150000
 | 
6.23e-01
 | 
| 
SIGNALING BY FGFR4
 | 
32
 | 
1.49e-01
 | 
-0.147000
 | 
3.30e-01
 | 
| 
REGULATION OF FZD BY UBIQUITINATION
 | 
13
 | 
3.58e-01
 | 
-0.147000
 | 
5.87e-01
 | 
| 
CELL EXTRACELLULAR MATRIX INTERACTIONS
 | 
18
 | 
2.80e-01
 | 
-0.147000
 | 
4.89e-01
 | 
| 
SELECTIVE AUTOPHAGY
 | 
63
 | 
4.40e-02
 | 
0.147000
 | 
1.42e-01
 | 
| 
PI 3K CASCADE FGFR4
 | 
12
 | 
3.79e-01
 | 
-0.147000
 | 
6.00e-01
 | 
| 
CYTOKINE SIGNALING IN IMMUNE SYSTEM
 | 
360
 | 
2.02e-06
 | 
-0.146000
 | 
4.32e-05
 | 
| 
REGULATION OF APC C ACTIVATORS BETWEEN G1 S AND EARLY ANAPHASE
 | 
32
 | 
1.52e-01
 | 
-0.146000
 | 
3.35e-01
 | 
| 
FRS MEDIATED FGFR3 SIGNALING
 | 
13
 | 
3.62e-01
 | 
-0.146000
 | 
5.88e-01
 | 
| 
DNA DOUBLE STRAND BREAK RESPONSE
 | 
41
 | 
1.06e-01
 | 
-0.146000
 | 
2.65e-01
 | 
| 
FCERI MEDIATED MAPK ACTIVATION
 | 
26
 | 
2.01e-01
 | 
-0.145000
 | 
4.03e-01
 | 
| 
SYNTHESIS OF PIPS AT THE GOLGI MEMBRANE
 | 
15
 | 
3.33e-01
 | 
-0.145000
 | 
5.52e-01
 | 
| 
SURFACTANT METABOLISM
 | 
14
 | 
3.53e-01
 | 
0.143000
 | 
5.80e-01
 | 
| 
SYNTHESIS OF PC
 | 
21
 | 
2.59e-01
 | 
0.142000
 | 
4.68e-01
 | 
| 
ERKS ARE INACTIVATED
 | 
13
 | 
3.75e-01
 | 
-0.142000
 | 
5.99e-01
 | 
| 
COMPLEMENT CASCADE
 | 
26
 | 
2.10e-01
 | 
0.142000
 | 
4.12e-01
 | 
| 
DEATH RECEPTOR SIGNALING
 | 
131
 | 
5.12e-03
 | 
-0.142000
 | 
2.63e-02
 | 
| 
PHASE I FUNCTIONALIZATION OF COMPOUNDS
 | 
56
 | 
6.82e-02
 | 
0.141000
 | 
1.90e-01
 | 
| 
REGULATION OF PTEN GENE TRANSCRIPTION
 | 
27
 | 
2.05e-01
 | 
0.141000
 | 
4.05e-01
 | 
| 
KERATAN SULFATE DEGRADATION
 | 
12
 | 
4.00e-01
 | 
-0.140000
 | 
6.14e-01
 | 
| 
SHC1 EVENTS IN EGFR SIGNALING
 | 
11
 | 
4.20e-01
 | 
-0.140000
 | 
6.32e-01
 | 
| 
SIGNALING BY ALK
 | 
14
 | 
3.64e-01
 | 
-0.140000
 | 
5.90e-01
 | 
| 
EGFR DOWNREGULATION
 | 
28
 | 
2.00e-01
 | 
-0.140000
 | 
4.01e-01
 | 
| 
CHROMATIN MODIFYING ENZYMES
 | 
136
 | 
5.16e-03
 | 
-0.139000
 | 
2.64e-02
 | 
| 
SPHINGOLIPID DE NOVO BIOSYNTHESIS
 | 
21
 | 
2.73e-01
 | 
-0.138000
 | 
4.84e-01
 | 
| 
CELL DEATH SIGNALLING VIA NRAGE NRIF AND NADE
 | 
66
 | 
5.46e-02
 | 
-0.137000
 | 
1.64e-01
 | 
| 
REGULATION OF INSULIN LIKE GROWTH FACTOR IGF TRANSPORT AND UPTAKE BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS
 | 
83
 | 
3.13e-02
 | 
-0.137000
 | 
1.10e-01
 | 
| 
GAP JUNCTION DEGRADATION
 | 
11
 | 
4.33e-01
 | 
-0.136000
 | 
6.47e-01
 | 
| 
REGULATION OF TP53 ACTIVITY
 | 
145
 | 
4.62e-03
 | 
-0.136000
 | 
2.46e-02
 | 
| 
SIGNALING BY EGFR
 | 
43
 | 
1.23e-01
 | 
-0.136000
 | 
2.93e-01
 | 
| 
NOD1 2 SIGNALING PATHWAY
 | 
30
 | 
1.99e-01
 | 
-0.135000
 | 
4.01e-01
 | 
| 
MET ACTIVATES RAP1 AND RAC1
 | 
11
 | 
4.38e-01
 | 
-0.135000
 | 
6.51e-01
 | 
| 
ORC1 REMOVAL FROM CHROMATIN
 | 
65
 | 
6.02e-02
 | 
-0.135000
 | 
1.74e-01
 | 
| 
REPRODUCTION
 | 
11
 | 
4.40e-01
 | 
-0.134000
 | 
6.52e-01
 | 
| 
GLUCAGON LIKE PEPTIDE 1 GLP1 REGULATES INSULIN SECRETION
 | 
24
 | 
2.55e-01
 | 
-0.134000
 | 
4.65e-01
 | 
| 
INSULIN RECEPTOR SIGNALLING CASCADE
 | 
33
 | 
1.84e-01
 | 
-0.134000
 | 
3.81e-01
 | 
| 
ACTIVATION OF MATRIX METALLOPROTEINASES
 | 
19
 | 
3.15e-01
 | 
0.133000
 | 
5.30e-01
 | 
| 
UNFOLDED PROTEIN RESPONSE UPR
 | 
10
 | 
4.70e-01
 | 
-0.132000
 | 
6.76e-01
 | 
| 
HYALURONAN UPTAKE AND DEGRADATION
 | 
11
 | 
4.49e-01
 | 
-0.132000
 | 
6.56e-01
 | 
| 
POST NMDA RECEPTOR ACTIVATION EVENTS
 | 
14
 | 
3.93e-01
 | 
-0.132000
 | 
6.08e-01
 | 
| 
FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION
 | 
99
 | 
2.39e-02
 | 
-0.132000
 | 
8.95e-02
 | 
| 
G ALPHA 12 13 SIGNALLING EVENTS
 | 
69
 | 
5.98e-02
 | 
-0.131000
 | 
1.74e-01
 | 
| 
REGULATION OF TP53 DEGRADATION
 | 
34
 | 
1.88e-01
 | 
-0.131000
 | 
3.87e-01
 | 
| 
MITOTIC SPINDLE CHECKPOINT
 | 
96
 | 
2.71e-02
 | 
-0.131000
 | 
9.84e-02
 | 
| 
RHOBTB GTPASE CYCLE
 | 
34
 | 
1.91e-01
 | 
-0.130000
 | 
3.92e-01
 | 
| 
TIE2 SIGNALING
 | 
16
 | 
3.72e-01
 | 
0.129000
 | 
5.97e-01
 | 
| 
IKK COMPLEX RECRUITMENT MEDIATED BY RIP1
 | 
22
 | 
2.96e-01
 | 
-0.129000
 | 
5.08e-01
 | 
| 
NOTCH HLH TRANSCRIPTION PATHWAY
 | 
22
 | 
2.97e-01
 | 
-0.129000
 | 
5.09e-01
 | 
| 
MITOTIC G2 G2 M PHASES
 | 
171
 | 
3.85e-03
 | 
-0.128000
 | 
2.15e-02
 | 
| 
M PHASE
 | 
312
 | 
1.03e-04
 | 
-0.128000
 | 
1.23e-03
 | 
| 
REGULATION OF TP53 ACTIVITY THROUGH PHOSPHORYLATION
 | 
86
 | 
4.02e-02
 | 
-0.128000
 | 
1.33e-01
 | 
| 
TNFR2 NON CANONICAL NF KB PATHWAY
 | 
75
 | 
5.58e-02
 | 
-0.128000
 | 
1.67e-01
 | 
| 
RHOBTB2 GTPASE CYCLE
 | 
22
 | 
3.00e-01
 | 
-0.128000
 | 
5.11e-01
 | 
| 
VEGFR2 MEDIATED CELL PROLIFERATION
 | 
12
 | 
4.45e-01
 | 
-0.127000
 | 
6.55e-01
 | 
| 
SYNTHESIS OF ACTIVE UBIQUITIN ROLES OF E1 AND E2 ENZYMES
 | 
30
 | 
2.28e-01
 | 
0.127000
 | 
4.39e-01
 | 
| 
SUMOYLATION OF INTRACELLULAR RECEPTORS
 | 
24
 | 
2.83e-01
 | 
0.127000
 | 
4.93e-01
 | 
| 
RNA POLYMERASE II TRANSCRIPTION TERMINATION
 | 
60
 | 
9.09e-02
 | 
-0.126000
 | 
2.37e-01
 | 
| 
SIGNALING BY FGFR1
 | 
41
 | 
1.65e-01
 | 
-0.125000
 | 
3.53e-01
 | 
| 
ATTENUATION PHASE
 | 
13
 | 
4.35e-01
 | 
0.125000
 | 
6.48e-01
 | 
| 
ORGANELLE BIOGENESIS AND MAINTENANCE
 | 
171
 | 
4.89e-03
 | 
-0.125000
 | 
2.54e-02
 | 
| 
CELLULAR RESPONSE TO HEAT STRESS
 | 
81
 | 
5.34e-02
 | 
0.124000
 | 
1.62e-01
 | 
| 
TRAF6 MEDIATED NF KB ACTIVATION
 | 
13
 | 
4.38e-01
 | 
-0.124000
 | 
6.51e-01
 | 
| 
INTERFERON SIGNALING
 | 
115
 | 
2.23e-02
 | 
-0.124000
 | 
8.53e-02
 | 
| 
KINESINS
 | 
47
 | 
1.45e-01
 | 
-0.123000
 | 
3.22e-01
 | 
| 
DOWNREGULATION OF ERBB2 ERBB3 SIGNALING
 | 
12
 | 
4.62e-01
 | 
-0.123000
 | 
6.67e-01
 | 
| 
CTLA4 INHIBITORY SIGNALING
 | 
20
 | 
3.42e-01
 | 
0.123000
 | 
5.64e-01
 | 
| 
DNA REPAIR
 | 
257
 | 
7.37e-04
 | 
-0.123000
 | 
6.11e-03
 | 
| 
RECYCLING PATHWAY OF L1
 | 
33
 | 
2.25e-01
 | 
-0.122000
 | 
4.37e-01
 | 
| 
SIGNALING BY RECEPTOR TYROSINE KINASES
 | 
359
 | 
7.56e-05
 | 
-0.122000
 | 
9.51e-04
 | 
| 
INWARDLY RECTIFYING K CHANNELS
 | 
25
 | 
2.92e-01
 | 
0.122000
 | 
5.03e-01
 | 
| 
LYSOSOME VESICLE BIOGENESIS
 | 
30
 | 
2.50e-01
 | 
0.121000
 | 
4.59e-01
 | 
| 
REGULATION OF TNFR1 SIGNALING
 | 
46
 | 
1.56e-01
 | 
-0.121000
 | 
3.41e-01
 | 
| 
SIGNALING BY INTERLEUKINS
 | 
222
 | 
1.94e-03
 | 
-0.121000
 | 
1.32e-02
 | 
| 
ADP SIGNALLING THROUGH P2Y PURINOCEPTOR 1
 | 
19
 | 
3.61e-01
 | 
-0.121000
 | 
5.88e-01
 | 
| 
FORMATION OF THE CORNIFIED ENVELOPE
 | 
17
 | 
3.89e-01
 | 
-0.121000
 | 
6.05e-01
 | 
| 
KERATINIZATION
 | 
17
 | 
3.89e-01
 | 
-0.121000
 | 
6.05e-01
 | 
| 
CARGO CONCENTRATION IN THE ER
 | 
29
 | 
2.63e-01
 | 
0.120000
 | 
4.72e-01
 | 
| 
NOREPINEPHRINE NEUROTRANSMITTER RELEASE CYCLE
 | 
11
 | 
4.96e-01
 | 
0.118000
 | 
6.99e-01
 | 
| 
TP53 REGULATES TRANSCRIPTION OF CELL DEATH GENES
 | 
14
 | 
4.45e-01
 | 
-0.118000
 | 
6.55e-01
 | 
| 
CHEMOKINE RECEPTORS BIND CHEMOKINES
 | 
20
 | 
3.62e-01
 | 
-0.118000
 | 
5.88e-01
 | 
| 
CELLULAR SENESCENCE
 | 
91
 | 
5.26e-02
 | 
-0.118000
 | 
1.60e-01
 | 
| 
PI 3K CASCADE FGFR1
 | 
12
 | 
4.81e-01
 | 
-0.118000
 | 
6.85e-01
 | 
| 
MHC CLASS II ANTIGEN PRESENTATION
 | 
98
 | 
4.47e-02
 | 
-0.117000
 | 
1.43e-01
 | 
| 
NEGATIVE REGULATION OF FGFR3 SIGNALING
 | 
23
 | 
3.30e-01
 | 
-0.117000
 | 
5.50e-01
 | 
| 
CALCINEURIN ACTIVATES NFAT
 | 
10
 | 
5.21e-01
 | 
-0.117000
 | 
7.19e-01
 | 
| 
CELLULAR RESPONSE TO CHEMICAL STRESS
 | 
145
 | 
1.51e-02
 | 
0.117000
 | 
6.17e-02
 | 
| 
PEPTIDE HORMONE METABOLISM
 | 
34
 | 
2.41e-01
 | 
0.116000
 | 
4.50e-01
 | 
| 
SIGNAL AMPLIFICATION
 | 
26
 | 
3.05e-01
 | 
-0.116000
 | 
5.16e-01
 | 
| 
GENERIC TRANSCRIPTION PATHWAY
 | 
690
 | 
2.85e-07
 | 
-0.115000
 | 
8.00e-06
 | 
| 
TRANSCRIPTIONAL REGULATION BY RUNX3
 | 
76
 | 
8.44e-02
 | 
-0.115000
 | 
2.24e-01
 | 
| 
L1CAM INTERACTIONS
 | 
63
 | 
1.16e-01
 | 
-0.114000
 | 
2.81e-01
 | 
| 
BLOOD GROUP SYSTEMS BIOSYNTHESIS
 | 
12
 | 
4.93e-01
 | 
0.114000
 | 
6.99e-01
 | 
| 
TOLL LIKE RECEPTOR 4 TLR4 CASCADE
 | 
112
 | 
3.70e-02
 | 
-0.114000
 | 
1.25e-01
 | 
| 
ANTIVIRAL MECHANISM BY IFN STIMULATED GENES
 | 
86
 | 
6.76e-02
 | 
-0.114000
 | 
1.89e-01
 | 
| 
RAF ACTIVATION
 | 
34
 | 
2.51e-01
 | 
0.114000
 | 
4.59e-01
 | 
| 
RND2 GTPASE CYCLE
 | 
37
 | 
2.36e-01
 | 
-0.113000
 | 
4.49e-01
 | 
| 
CA2 PATHWAY
 | 
37
 | 
2.36e-01
 | 
-0.113000
 | 
4.49e-01
 | 
| 
MITOTIC PROPHASE
 | 
67
 | 
1.12e-01
 | 
-0.112000
 | 
2.76e-01
 | 
| 
RUNX1 INTERACTS WITH CO FACTORS WHOSE PRECISE EFFECT ON RUNX1 TARGETS IS NOT KNOWN
 | 
32
 | 
2.74e-01
 | 
-0.112000
 | 
4.84e-01
 | 
| 
ESR MEDIATED SIGNALING
 | 
102
 | 
5.63e-02
 | 
-0.109000
 | 
1.67e-01
 | 
| 
PLATELET AGGREGATION PLUG FORMATION
 | 
30
 | 
3.02e-01
 | 
-0.109000
 | 
5.14e-01
 | 
| 
SIGNALING BY ACTIVIN
 | 
14
 | 
4.81e-01
 | 
0.109000
 | 
6.85e-01
 | 
| 
GOLGI CISTERNAE PERICENTRIOLAR STACK REORGANIZATION
 | 
10
 | 
5.52e-01
 | 
-0.109000
 | 
7.40e-01
 | 
| 
CD28 DEPENDENT PI3K AKT SIGNALING
 | 
21
 | 
3.89e-01
 | 
-0.109000
 | 
6.05e-01
 | 
| 
DUAL INCISION IN GG NER
 | 
41
 | 
2.29e-01
 | 
-0.109000
 | 
4.41e-01
 | 
| 
STIMULI SENSING CHANNELS
 | 
62
 | 
1.42e-01
 | 
0.108000
 | 
3.19e-01
 | 
| 
REGULATION OF LIPID METABOLISM BY PPARALPHA
 | 
16
 | 
4.57e-01
 | 
-0.107000
 | 
6.62e-01
 | 
| 
FGFR2 ALTERNATIVE SPLICING
 | 
17
 | 
4.44e-01
 | 
0.107000
 | 
6.55e-01
 | 
| 
METABOLISM OF NUCLEOTIDES
 | 
77
 | 
1.04e-01
 | 
0.107000
 | 
2.64e-01
 | 
| 
OPIOID SIGNALLING
 | 
59
 | 
1.57e-01
 | 
-0.107000
 | 
3.42e-01
 | 
| 
GENE EXPRESSION TRANSCRIPTION
 | 
921
 | 
5.54e-08
 | 
-0.107000
 | 
1.85e-06
 | 
| 
METHYLATION
 | 
13
 | 
5.07e-01
 | 
0.106000
 | 
7.05e-01
 | 
| 
SLC MEDIATED TRANSMEMBRANE TRANSPORT
 | 
168
 | 
1.79e-02
 | 
0.106000
 | 
7.08e-02
 | 
| 
HS GAG BIOSYNTHESIS
 | 
21
 | 
4.01e-01
 | 
-0.106000
 | 
6.14e-01
 | 
| 
DOWNSTREAM SIGNALING OF ACTIVATED FGFR1
 | 
21
 | 
4.02e-01
 | 
-0.106000
 | 
6.14e-01
 | 
| 
RECEPTOR TYPE TYROSINE PROTEIN PHOSPHATASES
 | 
14
 | 
4.94e-01
 | 
-0.106000
 | 
6.99e-01
 | 
| 
BINDING AND UPTAKE OF LIGANDS BY SCAVENGER RECEPTORS
 | 
23
 | 
3.81e-01
 | 
0.106000
 | 
6.02e-01
 | 
| 
REGULATION OF SIGNALING BY CBL
 | 
21
 | 
4.03e-01
 | 
-0.105000
 | 
6.14e-01
 | 
| 
MTORC1 MEDIATED SIGNALLING
 | 
24
 | 
3.72e-01
 | 
0.105000
 | 
5.97e-01
 | 
| 
CELL JUNCTION ORGANIZATION
 | 
59
 | 
1.63e-01
 | 
-0.105000
 | 
3.51e-01
 | 
| 
DNA REPLICATION PRE INITIATION
 | 
97
 | 
7.46e-02
 | 
-0.105000
 | 
2.02e-01
 | 
| 
FORMATION OF THE BETA CATENIN TCF TRANSACTIVATING COMPLEX
 | 
24
 | 
3.76e-01
 | 
0.104000
 | 
6.00e-01
 | 
| 
RNA POLYMERASE I TRANSCRIPTION
 | 
41
 | 
2.52e-01
 | 
-0.103000
 | 
4.61e-01
 | 
| 
ACTIVATION OF KAINATE RECEPTORS UPON GLUTAMATE BINDING
 | 
25
 | 
3.74e-01
 | 
-0.103000
 | 
5.99e-01
 | 
| 
IMMUNE SYSTEM
 | 
1247
 | 
1.72e-09
 | 
-0.103000
 | 
7.03e-08
 | 
| 
ERBB2 REGULATES CELL MOTILITY
 | 
12
 | 
5.40e-01
 | 
0.102000
 | 
7.34e-01
 | 
| 
INITIAL TRIGGERING OF COMPLEMENT
 | 
13
 | 
5.24e-01
 | 
0.102000
 | 
7.20e-01
 | 
| 
INSULIN RECEPTOR RECYCLING
 | 
24
 | 
3.88e-01
 | 
0.102000
 | 
6.05e-01
 | 
| 
PTK6 REGULATES RHO GTPASES RAS GTPASE AND MAP KINASES
 | 
12
 | 
5.42e-01
 | 
-0.102000
 | 
7.34e-01
 | 
| 
PLATELET ACTIVATION SIGNALING AND AGGREGATION
 | 
214
 | 
1.18e-02
 | 
-0.100000
 | 
5.16e-02
 | 
| 
NERVOUS SYSTEM DEVELOPMENT
 | 
235
 | 
8.48e-03
 | 
-0.099900
 | 
3.87e-02
 | 
| 
TGFBR3 PTM REGULATION
 | 
10
 | 
5.85e-01
 | 
-0.099700
 | 
7.68e-01
 | 
| 
SIGNALLING TO ERKS
 | 
25
 | 
3.88e-01
 | 
-0.099700
 | 
6.05e-01
 | 
| 
COPI MEDIATED ANTEROGRADE TRANSPORT
 | 
89
 | 
1.07e-01
 | 
-0.099100
 | 
2.65e-01
 | 
| 
TRIGLYCERIDE METABOLISM
 | 
12
 | 
5.53e-01
 | 
0.099000
 | 
7.40e-01
 | 
| 
RHOJ GTPASE CYCLE
 | 
15
 | 
5.10e-01
 | 
-0.098300
 | 
7.06e-01
 | 
| 
INTERLEUKIN 1 FAMILY SIGNALING
 | 
105
 | 
8.23e-02
 | 
-0.098200
 | 
2.19e-01
 | 
| 
PYROPTOSIS
 | 
16
 | 
4.97e-01
 | 
-0.098100
 | 
6.99e-01
 | 
| 
FRS MEDIATED FGFR2 SIGNALING
 | 
14
 | 
5.27e-01
 | 
-0.097700
 | 
7.20e-01
 | 
| 
TRANSPORT OF SMALL MOLECULES
 | 
500
 | 
2.02e-04
 | 
0.097600
 | 
2.19e-03
 | 
| 
SUMOYLATION OF RNA BINDING PROTEINS
 | 
45
 | 
2.58e-01
 | 
-0.097400
 | 
4.68e-01
 | 
| 
BASE EXCISION REPAIR
 | 
42
 | 
2.75e-01
 | 
-0.097400
 | 
4.84e-01
 | 
| 
GLYCOSPHINGOLIPID BIOSYNTHESIS
 | 
14
 | 
5.29e-01
 | 
0.097200
 | 
7.21e-01
 | 
| 
TRANSPORT OF MATURE TRANSCRIPT TO CYTOPLASM
 | 
74
 | 
1.48e-01
 | 
-0.097200
 | 
3.29e-01
 | 
| 
CHAPERONIN MEDIATED PROTEIN FOLDING
 | 
31
 | 
3.50e-01
 | 
-0.097000
 | 
5.76e-01
 | 
| 
REGULATION OF INNATE IMMUNE RESPONSES TO CYTOSOLIC DNA
 | 
11
 | 
5.79e-01
 | 
0.096700
 | 
7.62e-01
 | 
| 
IRS MEDIATED SIGNALLING
 | 
28
 | 
3.76e-01
 | 
-0.096700
 | 
6.00e-01
 | 
| 
ERYTHROCYTES TAKE UP CARBON DIOXIDE AND RELEASE OXYGEN
 | 
10
 | 
5.98e-01
 | 
0.096400
 | 
7.74e-01
 | 
| 
NEDDYLATION
 | 
207
 | 
1.70e-02
 | 
0.096400
 | 
6.87e-02
 | 
| 
SUMOYLATION OF UBIQUITINYLATION PROTEINS
 | 
37
 | 
3.12e-01
 | 
-0.096100
 | 
5.27e-01
 | 
| 
SEPARATION OF SISTER CHROMATIDS
 | 
165
 | 
3.46e-02
 | 
-0.095500
 | 
1.18e-01
 | 
| 
PHOSPHOLIPID METABOLISM
 | 
157
 | 
4.12e-02
 | 
0.094600
 | 
1.35e-01
 | 
| 
HEMOSTASIS
 | 
424
 | 
9.40e-04
 | 
-0.094100
 | 
7.49e-03
 | 
| 
FORMATION OF FIBRIN CLOT CLOTTING CASCADE
 | 
19
 | 
4.79e-01
 | 
-0.093900
 | 
6.85e-01
 | 
| 
SWITCHING OF ORIGINS TO A POST REPLICATIVE STATE
 | 
86
 | 
1.34e-01
 | 
-0.093500
 | 
3.07e-01
 | 
| 
MITOTIC METAPHASE AND ANAPHASE
 | 
202
 | 
2.23e-02
 | 
-0.093500
 | 
8.53e-02
 | 
| 
NEGATIVE REGULATORS OF DDX58 IFIH1 SIGNALING
 | 
13
 | 
5.60e-01
 | 
0.093400
 | 
7.46e-01
 | 
| 
NEGATIVE REGULATION OF THE PI3K AKT NETWORK
 | 
90
 | 
1.27e-01
 | 
-0.093100
 | 
2.97e-01
 | 
| 
TOLL LIKE RECEPTOR CASCADES
 | 
138
 | 
5.94e-02
 | 
-0.093100
 | 
1.73e-01
 | 
| 
ABC FAMILY PROTEINS MEDIATED TRANSPORT
 | 
90
 | 
1.27e-01
 | 
0.093100
 | 
2.97e-01
 | 
| 
GAP JUNCTION TRAFFICKING AND REGULATION
 | 
30
 | 
3.78e-01
 | 
-0.093000
 | 
6.00e-01
 | 
| 
INTEGRIN SIGNALING
 | 
26
 | 
4.12e-01
 | 
-0.093000
 | 
6.23e-01
 | 
| 
INTERFERON GAMMA SIGNALING
 | 
18
 | 
4.96e-01
 | 
-0.092800
 | 
6.99e-01
 | 
| 
PROCESSING AND ACTIVATION OF SUMO
 | 
10
 | 
6.13e-01
 | 
-0.092400
 | 
7.84e-01
 | 
| 
GAMMA CARBOXYLATION HYPUSINYLATION HYDROXYLATION AND ARYLSULFATASE ACTIVATION
 | 
45
 | 
2.84e-01
 | 
0.092300
 | 
4.93e-01
 | 
| 
CYCLIN A CDK2 ASSOCIATED EVENTS AT S PHASE ENTRY
 | 
68
 | 
1.89e-01
 | 
-0.092100
 | 
3.90e-01
 | 
| 
SENESCENCE ASSOCIATED SECRETORY PHENOTYPE SASP
 | 
38
 | 
3.26e-01
 | 
-0.092000
 | 
5.45e-01
 | 
| 
NICOTINATE METABOLISM
 | 
25
 | 
4.28e-01
 | 
-0.091600
 | 
6.40e-01
 | 
| 
HEDGEHOG ON STATE
 | 
75
 | 
1.71e-01
 | 
-0.091600
 | 
3.62e-01
 | 
| 
SUMOYLATION OF CHROMATIN ORGANIZATION PROTEINS
 | 
51
 | 
2.61e-01
 | 
-0.091100
 | 
4.68e-01
 | 
| 
WNT5A DEPENDENT INTERNALIZATION OF FZD4
 | 
14
 | 
5.57e-01
 | 
-0.090700
 | 
7.44e-01
 | 
| 
GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK
 | 
14
 | 
5.58e-01
 | 
-0.090500
 | 
7.44e-01
 | 
| 
NEGATIVE REGULATION OF FGFR2 SIGNALING
 | 
24
 | 
4.44e-01
 | 
-0.090300
 | 
6.55e-01
 | 
| 
INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES
 | 
21
 | 
4.80e-01
 | 
0.089100
 | 
6.85e-01
 | 
| 
TOLL LIKE RECEPTOR 9 TLR9 CASCADE
 | 
93
 | 
1.39e-01
 | 
-0.088900
 | 
3.14e-01
 | 
| 
INNATE IMMUNE SYSTEM
 | 
712
 | 
6.13e-05
 | 
-0.088800
 | 
8.00e-04
 | 
| 
TRANSCRIPTIONAL REGULATION BY RUNX1
 | 
120
 | 
9.48e-02
 | 
-0.088400
 | 
2.45e-01
 | 
| 
MRNA SPLICING MINOR PATHWAY
 | 
47
 | 
3.00e-01
 | 
0.087400
 | 
5.11e-01
 | 
| 
NUCLEAR PORE COMPLEX NPC DISASSEMBLY
 | 
30
 | 
4.09e-01
 | 
-0.087200
 | 
6.20e-01
 | 
| 
AGGREPHAGY
 | 
28
 | 
4.26e-01
 | 
-0.087000
 | 
6.38e-01
 | 
| 
INTRA GOLGI AND RETROGRADE GOLGI TO ER TRAFFIC
 | 
169
 | 
5.40e-02
 | 
-0.086100
 | 
1.63e-01
 | 
| 
RHO GTPASES ACTIVATE IQGAPS
 | 
26
 | 
4.48e-01
 | 
-0.085900
 | 
6.56e-01
 | 
| 
REGULATED PROTEOLYSIS OF P75NTR
 | 
10
 | 
6.39e-01
 | 
0.085700
 | 
8.00e-01
 | 
| 
GLUCOSE METABOLISM
 | 
64
 | 
2.37e-01
 | 
0.085500
 | 
4.49e-01
 | 
| 
FANCONI ANEMIA PATHWAY
 | 
33
 | 
4.03e-01
 | 
-0.084100
 | 
6.14e-01
 | 
| 
BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN
 | 
65
 | 
2.42e-01
 | 
0.083900
 | 
4.51e-01
 | 
| 
REGULATION OF TBK1 IKK IKBKE MEDIATED ACTIVATION OF IRF3 IRF7
 | 
14
 | 
5.89e-01
 | 
-0.083400
 | 
7.70e-01
 | 
| 
SIGNALING BY HEDGEHOG
 | 
125
 | 
1.08e-01
 | 
-0.083400
 | 
2.67e-01
 | 
| 
GOLGI TO ER RETROGRADE TRANSPORT
 | 
116
 | 
1.22e-01
 | 
-0.083200
 | 
2.91e-01
 | 
| 
G ALPHA Z SIGNALLING EVENTS
 | 
27
 | 
4.57e-01
 | 
-0.082700
 | 
6.62e-01
 | 
| 
MYD88 MAL TIRAP CASCADE INITIATED ON PLASMA MEMBRANE
 | 
81
 | 
2.00e-01
 | 
-0.082400
 | 
4.01e-01
 | 
| 
METABOLISM OF PROTEINS
 | 
1445
 | 
2.77e-07
 | 
0.082000
 | 
8.00e-06
 | 
| 
APC CDC20 MEDIATED DEGRADATION OF NEK2A
 | 
26
 | 
4.71e-01
 | 
-0.081800
 | 
6.76e-01
 | 
| 
PROCESSING OF CAPPED INTRONLESS PRE MRNA
 | 
28
 | 
4.55e-01
 | 
-0.081600
 | 
6.62e-01
 | 
| 
SIGNALING BY NOTCH1
 | 
18
 | 
5.49e-01
 | 
-0.081600
 | 
7.39e-01
 | 
| 
FRS MEDIATED FGFR4 SIGNALING
 | 
13
 | 
6.12e-01
 | 
-0.081300
 | 
7.84e-01
 | 
| 
RAS PROCESSING
 | 
23
 | 
5.02e-01
 | 
0.080800
 | 
7.04e-01
 | 
| 
NEGATIVE REGULATION OF FGFR4 SIGNALING
 | 
23
 | 
5.03e-01
 | 
-0.080700
 | 
7.04e-01
 | 
| 
TRANSPORT OF THE SLBP DEPENDANT MATURE MRNA
 | 
34
 | 
4.18e-01
 | 
-0.080300
 | 
6.29e-01
 | 
| 
SEROTONIN NEUROTRANSMITTER RELEASE CYCLE
 | 
11
 | 
6.46e-01
 | 
-0.080100
 | 
8.04e-01
 | 
| 
DEVELOPMENTAL BIOLOGY
 | 
316
 | 
1.49e-02
 | 
-0.079900
 | 
6.13e-02
 | 
| 
SYNTHESIS OF IP3 AND IP4 IN THE CYTOSOL
 | 
23
 | 
5.08e-01
 | 
-0.079800
 | 
7.05e-01
 | 
| 
SIGNALING BY THE B CELL RECEPTOR BCR
 | 
94
 | 
1.82e-01
 | 
-0.079800
 | 
3.79e-01
 | 
| 
RESOLUTION OF ABASIC SITES AP SITES
 | 
37
 | 
4.02e-01
 | 
-0.079700
 | 
6.14e-01
 | 
| 
REGULATION OF RAS BY GAPS
 | 
63
 | 
2.75e-01
 | 
-0.079500
 | 
4.84e-01
 | 
| 
GAB1 SIGNALOSOME
 | 
15
 | 
5.95e-01
 | 
-0.079300
 | 
7.74e-01
 | 
| 
ION CHANNEL TRANSPORT
 | 
118
 | 
1.38e-01
 | 
0.079100
 | 
3.14e-01
 | 
| 
COPI DEPENDENT GOLGI TO ER RETROGRADE TRAFFIC
 | 
86
 | 
2.06e-01
 | 
-0.078900
 | 
4.06e-01
 | 
| 
VASOPRESSIN REGULATES RENAL WATER HOMEOSTASIS VIA AQUAPORINS
 | 
22
 | 
5.26e-01
 | 
-0.078100
 | 
7.20e-01
 | 
| 
INTRA GOLGI TRAFFIC
 | 
33
 | 
4.40e-01
 | 
-0.077800
 | 
6.52e-01
 | 
| 
TCR SIGNALING
 | 
90
 | 
2.03e-01
 | 
-0.077700
 | 
4.05e-01
 | 
| 
RAP1 SIGNALLING
 | 
15
 | 
6.04e-01
 | 
0.077400
 | 
7.81e-01
 | 
| 
RAB GEFS EXCHANGE GTP FOR GDP ON RABS
 | 
84
 | 
2.22e-01
 | 
-0.077200
 | 
4.33e-01
 | 
| 
HYALURONAN METABOLISM
 | 
14
 | 
6.20e-01
 | 
-0.076600
 | 
7.91e-01
 | 
| 
SIGNALING BY ERYTHROPOIETIN
 | 
16
 | 
5.97e-01
 | 
-0.076400
 | 
7.74e-01
 | 
| 
CS DS DEGRADATION
 | 
11
 | 
6.63e-01
 | 
-0.075800
 | 
8.16e-01
 | 
| 
COPII MEDIATED VESICLE TRANSPORT
 | 
66
 | 
2.88e-01
 | 
0.075700
 | 
4.98e-01
 | 
| 
MYOGENESIS
 | 
17
 | 
5.90e-01
 | 
-0.075500
 | 
7.71e-01
 | 
| 
TNF SIGNALING
 | 
55
 | 
3.33e-01
 | 
-0.075500
 | 
5.52e-01
 | 
| 
DEUBIQUITINATION
 | 
216
 | 
5.70e-02
 | 
-0.075300
 | 
1.68e-01
 | 
| 
GAP JUNCTION ASSEMBLY
 | 
18
 | 
5.81e-01
 | 
-0.075300
 | 
7.64e-01
 | 
| 
JNK C JUN KINASES PHOSPHORYLATION AND ACTIVATION MEDIATED BY ACTIVATED HUMAN TAK1
 | 
22
 | 
5.43e-01
 | 
-0.074900
 | 
7.34e-01
 | 
| 
TELOMERE EXTENSION BY TELOMERASE
 | 
17
 | 
5.96e-01
 | 
-0.074300
 | 
7.74e-01
 | 
| 
RHOBTB1 GTPASE CYCLE
 | 
22
 | 
5.46e-01
 | 
-0.074300
 | 
7.37e-01
 | 
| 
SYNAPTIC ADHESION LIKE MOLECULES
 | 
15
 | 
6.20e-01
 | 
0.073900
 | 
7.91e-01
 | 
| 
SIGNALING BY FGFR
 | 
62
 | 
3.16e-01
 | 
-0.073700
 | 
5.30e-01
 | 
| 
SUMOYLATION OF SUMOYLATION PROTEINS
 | 
33
 | 
4.66e-01
 | 
-0.073300
 | 
6.73e-01
 | 
| 
TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR
 | 
11
 | 
6.74e-01
 | 
-0.073200
 | 
8.23e-01
 | 
| 
INOSITOL PHOSPHATE METABOLISM
 | 
42
 | 
4.13e-01
 | 
0.073000
 | 
6.24e-01
 | 
| 
NEURONAL SYSTEM
 | 
202
 | 
7.50e-02
 | 
0.072800
 | 
2.02e-01
 | 
| 
CD28 DEPENDENT VAV1 PATHWAY
 | 
11
 | 
6.76e-01
 | 
-0.072800
 | 
8.23e-01
 | 
| 
ADAPTIVE IMMUNE SYSTEM
 | 
566
 | 
3.30e-03
 | 
-0.072700
 | 
1.91e-02
 | 
| 
COSTIMULATION BY THE CD28 FAMILY
 | 
52
 | 
3.65e-01
 | 
-0.072600
 | 
5.90e-01
 | 
| 
APC C MEDIATED DEGRADATION OF CELL CYCLE PROTEINS
 | 
81
 | 
2.59e-01
 | 
-0.072500
 | 
4.68e-01
 | 
| 
ROLE OF LAT2 NTAL LAB ON CALCIUM MOBILIZATION
 | 
12
 | 
6.66e-01
 | 
-0.072100
 | 
8.16e-01
 | 
| 
N GLYCAN TRIMMING IN THE ER AND CALNEXIN CALRETICULIN CYCLE
 | 
15
 | 
6.30e-01
 | 
0.071900
 | 
7.95e-01
 | 
| 
TERMINATION OF O GLYCAN BIOSYNTHESIS
 | 
10
 | 
6.95e-01
 | 
-0.071700
 | 
8.37e-01
 | 
| 
INITIATION OF NUCLEAR ENVELOPE NE REFORMATION
 | 
16
 | 
6.26e-01
 | 
-0.070400
 | 
7.94e-01
 | 
| 
RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2
 | 
110
 | 
2.08e-01
 | 
-0.069500
 | 
4.09e-01
 | 
| 
ADENYLATE CYCLASE INHIBITORY PATHWAY
 | 
13
 | 
6.66e-01
 | 
-0.069200
 | 
8.16e-01
 | 
| 
G ALPHA Q SIGNALLING EVENTS
 | 
116
 | 
1.98e-01
 | 
-0.069200
 | 
4.01e-01
 | 
| 
INTERLEUKIN 1 SIGNALING
 | 
96
 | 
2.43e-01
 | 
-0.069100
 | 
4.51e-01
 | 
| 
PROCESSING OF CAPPED INTRON CONTAINING PRE MRNA
 | 
254
 | 
5.89e-02
 | 
-0.069000
 | 
1.72e-01
 | 
| 
MET RECEPTOR RECYCLING
 | 
10
 | 
7.06e-01
 | 
0.068800
 | 
8.44e-01
 | 
| 
GLUTAMATE NEUROTRANSMITTER RELEASE CYCLE
 | 
16
 | 
6.34e-01
 | 
0.068700
 | 
7.99e-01
 | 
| 
TRANSCRIPTION COUPLED NUCLEOTIDE EXCISION REPAIR TC NER
 | 
73
 | 
3.13e-01
 | 
-0.068400
 | 
5.27e-01
 | 
| 
CELLULAR RESPONSES TO STIMULI
 | 
420
 | 
1.79e-02
 | 
0.067600
 | 
7.08e-02
 | 
| 
DOWNREGULATION OF ERBB2 SIGNALING
 | 
24
 | 
5.67e-01
 | 
0.067500
 | 
7.52e-01
 | 
| 
ZBP1 DAI MEDIATED INDUCTION OF TYPE I IFNS
 | 
13
 | 
6.75e-01
 | 
-0.067200
 | 
8.23e-01
 | 
| 
G ALPHA S SIGNALLING EVENTS
 | 
62
 | 
3.61e-01
 | 
-0.067100
 | 
5.88e-01
 | 
| 
AZATHIOPRINE ADME
 | 
20
 | 
6.05e-01
 | 
0.066800
 | 
7.81e-01
 | 
| 
TBC RABGAPS
 | 
33
 | 
5.09e-01
 | 
0.066500
 | 
7.06e-01
 | 
| 
IONOTROPIC ACTIVITY OF KAINATE RECEPTORS
 | 
10
 | 
7.19e-01
 | 
0.065700
 | 
8.52e-01
 | 
| 
NR1H2 AND NR1H3 MEDIATED SIGNALING
 | 
12
 | 
6.95e-01
 | 
0.065400
 | 
8.37e-01
 | 
| 
SCF SKP2 MEDIATED DEGRADATION OF P27 P21
 | 
56
 | 
4.00e-01
 | 
-0.065100
 | 
6.14e-01
 | 
| 
AKT PHOSPHORYLATES TARGETS IN THE NUCLEUS
 | 
10
 | 
7.22e-01
 | 
-0.065100
 | 
8.53e-01
 | 
| 
INHIBITION OF THE PROTEOLYTIC ACTIVITY OF APC C REQUIRED FOR THE ONSET OF ANAPHASE BY MITOTIC SPINDLE CHECKPOINT COMPONENTS
 | 
21
 | 
6.06e-01
 | 
-0.065100
 | 
7.81e-01
 | 
| 
TRANSPORT OF MATURE MRNAS DERIVED FROM INTRONLESS TRANSCRIPTS
 | 
41
 | 
4.71e-01
 | 
-0.065000
 | 
6.76e-01
 | 
| 
INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1
 | 
10
 | 
7.24e-01
 | 
-0.064400
 | 
8.53e-01
 | 
| 
PKR MEDIATED SIGNALING
 | 
60
 | 
3.89e-01
 | 
-0.064400
 | 
6.05e-01
 | 
| 
NEUROTRANSMITTER RELEASE CYCLE
 | 
30
 | 
5.43e-01
 | 
0.064200
 | 
7.34e-01
 | 
| 
CLATHRIN MEDIATED ENDOCYTOSIS
 | 
120
 | 
2.26e-01
 | 
-0.064100
 | 
4.38e-01
 | 
| 
MAP2K AND MAPK ACTIVATION
 | 
36
 | 
5.07e-01
 | 
-0.063900
 | 
7.05e-01
 | 
| 
DUAL INCISION IN TC NER
 | 
61
 | 
3.92e-01
 | 
-0.063300
 | 
6.08e-01
 | 
| 
UCH PROTEINASES
 | 
77
 | 
3.40e-01
 | 
0.063000
 | 
5.62e-01
 | 
| 
DEADENYLATION DEPENDENT MRNA DECAY
 | 
48
 | 
4.52e-01
 | 
-0.062800
 | 
6.59e-01
 | 
| 
INTERLEUKIN 17 SIGNALING
 | 
57
 | 
4.16e-01
 | 
-0.062400
 | 
6.27e-01
 | 
| 
G1 S DNA DAMAGE CHECKPOINTS
 | 
61
 | 
4.00e-01
 | 
-0.062300
 | 
6.14e-01
 | 
| 
NEGATIVE REGULATION OF MAPK PATHWAY
 | 
41
 | 
4.92e-01
 | 
0.062000
 | 
6.99e-01
 | 
| 
SIGNALING BY FGFR2
 | 
51
 | 
4.50e-01
 | 
-0.061200
 | 
6.58e-01
 | 
| 
REGULATION OF BACH1 ACTIVITY
 | 
10
 | 
7.38e-01
 | 
-0.061000
 | 
8.59e-01
 | 
| 
SHC1 EVENTS IN ERBB2 SIGNALING
 | 
13
 | 
7.04e-01
 | 
0.060900
 | 
8.42e-01
 | 
| 
SIGNALING BY ERBB2
 | 
40
 | 
5.05e-01
 | 
-0.060900
 | 
7.05e-01
 | 
| 
RNA POLYMERASE III TRANSCRIPTION
 | 
34
 | 
5.42e-01
 | 
0.060500
 | 
7.34e-01
 | 
| 
RHO GTPASES ACTIVATE PAKS
 | 
22
 | 
6.26e-01
 | 
0.060100
 | 
7.94e-01
 | 
| 
RNA POLYMERASE II PROMOTER ESCAPE
 | 
44
 | 
4.95e-01
 | 
0.059400
 | 
6.99e-01
 | 
| 
CELLULAR RESPONSE TO HYPOXIA
 | 
65
 | 
4.08e-01
 | 
0.059400
 | 
6.20e-01
 | 
| 
O LINKED GLYCOSYLATION
 | 
72
 | 
3.85e-01
 | 
-0.059200
 | 
6.05e-01
 | 
| 
NUCLEAR ENVELOPE BREAKDOWN
 | 
45
 | 
4.95e-01
 | 
-0.058800
 | 
6.99e-01
 | 
| 
NEUREXINS AND NEUROLIGINS
 | 
21
 | 
6.41e-01
 | 
0.058700
 | 
8.01e-01
 | 
| 
TRANSCRIPTIONAL REGULATION BY TP53
 | 
274
 | 
9.62e-02
 | 
-0.058500
 | 
2.47e-01
 | 
| 
NUCLEAR EVENTS MEDIATED BY NFE2L2
 | 
53
 | 
4.62e-01
 | 
0.058500
 | 
6.67e-01
 | 
| 
NUCLEOTIDE EXCISION REPAIR
 | 
105
 | 
3.03e-01
 | 
-0.058300
 | 
5.14e-01
 | 
| 
GLYCOSPHINGOLIPID METABOLISM
 | 
42
 | 
5.14e-01
 | 
0.058300
 | 
7.09e-01
 | 
| 
ACTIVATION OF G PROTEIN GATED POTASSIUM CHANNELS
 | 
20
 | 
6.54e-01
 | 
0.058000
 | 
8.10e-01
 | 
| 
COPI INDEPENDENT GOLGI TO ER RETROGRADE TRAFFIC
 | 
42
 | 
5.25e-01
 | 
-0.056700
 | 
7.20e-01
 | 
| 
INTERLEUKIN 3 INTERLEUKIN 5 AND GM CSF SIGNALING
 | 
36
 | 
5.61e-01
 | 
-0.056000
 | 
7.46e-01
 | 
| 
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 1 PROMOTER
 | 
27
 | 
6.15e-01
 | 
0.056000
 | 
7.86e-01
 | 
| 
GLOBAL GENOME NUCLEOTIDE EXCISION REPAIR GG NER
 | 
81
 | 
3.88e-01
 | 
-0.055500
 | 
6.05e-01
 | 
| 
ACTIVATION OF NMDA RECEPTORS AND POSTSYNAPTIC EVENTS
 | 
28
 | 
6.11e-01
 | 
0.055500
 | 
7.84e-01
 | 
| 
PURINE SALVAGE
 | 
11
 | 
7.50e-01
 | 
-0.055500
 | 
8.67e-01
 | 
| 
FRS MEDIATED FGFR1 SIGNALING
 | 
13
 | 
7.34e-01
 | 
-0.054400
 | 
8.59e-01
 | 
| 
REGULATION OF TP53 ACTIVITY THROUGH ASSOCIATION WITH CO FACTORS
 | 
11
 | 
7.55e-01
 | 
-0.054300
 | 
8.67e-01
 | 
| 
NEUTROPHIL DEGRANULATION
 | 
386
 | 
7.06e-02
 | 
-0.053800
 | 
1.96e-01
 | 
| 
MITF M REGULATED MELANOCYTE DEVELOPMENT
 | 
29
 | 
6.25e-01
 | 
-0.052500
 | 
7.94e-01
 | 
| 
INTRAFLAGELLAR TRANSPORT
 | 
40
 | 
5.69e-01
 | 
-0.052100
 | 
7.53e-01
 | 
| 
DEGRADATION OF DVL
 | 
53
 | 
5.13e-01
 | 
0.052000
 | 
7.09e-01
 | 
| 
DISSOLUTION OF FIBRIN CLOT
 | 
10
 | 
7.79e-01
 | 
0.051300
 | 
8.78e-01
 | 
| 
AQUAPORIN MEDIATED TRANSPORT
 | 
25
 | 
6.58e-01
 | 
-0.051200
 | 
8.13e-01
 | 
| 
PHOSPHORYLATION OF THE APC C
 | 
19
 | 
7.02e-01
 | 
-0.050600
 | 
8.42e-01
 | 
| 
ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT
 | 
29
 | 
6.38e-01
 | 
-0.050500
 | 
7.99e-01
 | 
| 
BASE EXCISION REPAIR AP SITE FORMATION
 | 
15
 | 
7.35e-01
 | 
0.050500
 | 
8.59e-01
 | 
| 
MRNA DECAY BY 5 TO 3 EXORIBONUCLEASE
 | 
14
 | 
7.45e-01
 | 
0.050300
 | 
8.63e-01
 | 
| 
DOWNSTREAM SIGNAL TRANSDUCTION
 | 
26
 | 
6.58e-01
 | 
-0.050100
 | 
8.13e-01
 | 
| 
EPHA MEDIATED GROWTH CONE COLLAPSE
 | 
12
 | 
7.64e-01
 | 
-0.050100
 | 
8.74e-01
 | 
| 
INTERLEUKIN 20 FAMILY SIGNALING
 | 
11
 | 
7.74e-01
 | 
0.050100
 | 
8.76e-01
 | 
| 
TRISTETRAPROLIN TTP ZFP36 BINDS AND DESTABILIZES MRNA
 | 
16
 | 
7.30e-01
 | 
-0.049900
 | 
8.58e-01
 | 
| 
TRAFFICKING OF AMPA RECEPTORS
 | 
22
 | 
6.87e-01
 | 
0.049600
 | 
8.33e-01
 | 
| 
SIGNALING BY GPCR
 | 
323
 | 
1.27e-01
 | 
-0.049500
 | 
2.97e-01
 | 
| 
MRNA SPLICING
 | 
190
 | 
2.41e-01
 | 
-0.049400
 | 
4.50e-01
 | 
| 
BETA CATENIN INDEPENDENT WNT SIGNALING
 | 
112
 | 
3.70e-01
 | 
-0.049100
 | 
5.95e-01
 | 
| 
ASSEMBLY OF THE PRE REPLICATIVE COMPLEX
 | 
81
 | 
4.47e-01
 | 
-0.048900
 | 
6.56e-01
 | 
| 
C TYPE LECTIN RECEPTORS CLRS
 | 
104
 | 
3.90e-01
 | 
-0.048800
 | 
6.06e-01
 | 
| 
FORMATION OF THE EARLY ELONGATION COMPLEX
 | 
32
 | 
6.35e-01
 | 
0.048500
 | 
7.99e-01
 | 
| 
KEAP1 NFE2L2 PATHWAY
 | 
73
 | 
4.75e-01
 | 
-0.048400
 | 
6.81e-01
 | 
| 
SIGNALING BY ROBO RECEPTORS
 | 
20
 | 
7.08e-01
 | 
-0.048300
 | 
8.45e-01
 | 
| 
PLATELET HOMEOSTASIS
 | 
64
 | 
5.04e-01
 | 
-0.048300
 | 
7.05e-01
 | 
| 
RUNX1 REGULATES GENES INVOLVED IN MEGAKARYOCYTE DIFFERENTIATION AND PLATELET FUNCTION
 | 
19
 | 
7.16e-01
 | 
-0.048200
 | 
8.51e-01
 | 
| 
RETROGRADE TRANSPORT AT THE TRANS GOLGI NETWORK
 | 
44
 | 
5.85e-01
 | 
-0.047700
 | 
7.68e-01
 | 
| 
ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION
 | 
23
 | 
6.95e-01
 | 
0.047300
 | 
8.37e-01
 | 
| 
MITF M DEPENDENT GENE EXPRESSION
 | 
15
 | 
7.52e-01
 | 
0.047200
 | 
8.67e-01
 | 
| 
ACTIVATION OF IRF3 IRF7 MEDIATED BY TBK1 IKK IKBKE
 | 
17
 | 
7.37e-01
 | 
-0.047100
 | 
8.59e-01
 | 
| 
TRANSMISSION ACROSS CHEMICAL SYNAPSES
 | 
130
 | 
3.60e-01
 | 
0.046600
 | 
5.88e-01
 | 
| 
RNA POLYMERASE III TRANSCRIPTION INITIATION FROM TYPE 3 PROMOTER
 | 
26
 | 
6.82e-01
 | 
0.046500
 | 
8.28e-01
 | 
| 
NUCLEOTIDE CATABOLISM
 | 
28
 | 
6.71e-01
 | 
0.046300
 | 
8.22e-01
 | 
| 
SIGNALING BY NOTCH
 | 
38
 | 
6.23e-01
 | 
-0.046100
 | 
7.93e-01
 | 
| 
ION TRANSPORT BY P TYPE ATPASES
 | 
41
 | 
6.10e-01
 | 
-0.046000
 | 
7.84e-01
 | 
| 
MRNA CAPPING
 | 
28
 | 
6.74e-01
 | 
0.046000
 | 
8.23e-01
 | 
| 
OTHER SEMAPHORIN INTERACTIONS
 | 
14
 | 
7.66e-01
 | 
0.045900
 | 
8.74e-01
 | 
| 
LDL CLEARANCE
 | 
15
 | 
7.59e-01
 | 
0.045800
 | 
8.70e-01
 | 
| 
PKA MEDIATED PHOSPHORYLATION OF CREB
 | 
16
 | 
7.52e-01
 | 
-0.045600
 | 
8.67e-01
 | 
| 
INTRACELLULAR SIGNALING BY SECOND MESSENGERS
 | 
224
 | 
2.45e-01
 | 
-0.045200
 | 
4.54e-01
 | 
| 
TRANSCRIPTIONAL AND POST TRANSLATIONAL REGULATION OF MITF M EXPRESSION AND ACTIVITY
 | 
16
 | 
7.55e-01
 | 
-0.045000
 | 
8.67e-01
 | 
| 
METABOLISM OF FOLATE AND PTERINES
 | 
17
 | 
7.49e-01
 | 
-0.044800
 | 
8.67e-01
 | 
| 
RET SIGNALING
 | 
34
 | 
6.52e-01
 | 
0.044700
 | 
8.10e-01
 | 
| 
E3 UBIQUITIN LIGASES UBIQUITINATE TARGET PROTEINS
 | 
36
 | 
6.44e-01
 | 
-0.044600
 | 
8.02e-01
 | 
| 
TRANSCRIPTIONAL REGULATION BY RUNX2
 | 
60
 | 
5.51e-01
 | 
-0.044600
 | 
7.40e-01
 | 
| 
WNT5A DEPENDENT INTERNALIZATION OF FZD2 FZD5 AND ROR2
 | 
12
 | 
7.90e-01
 | 
0.044500
 | 
8.86e-01
 | 
| 
ANTIMICROBIAL PEPTIDES
 | 
11
 | 
7.99e-01
 | 
0.044300
 | 
8.94e-01
 | 
| 
PLASMA LIPOPROTEIN ASSEMBLY REMODELING AND CLEARANCE
 | 
51
 | 
5.87e-01
 | 
0.044000
 | 
7.69e-01
 | 
| 
NRIF SIGNALS CELL DEATH FROM THE NUCLEUS
 | 
14
 | 
7.76e-01
 | 
0.044000
 | 
8.77e-01
 | 
| 
HATS ACETYLATE HISTONES
 | 
29
 | 
6.84e-01
 | 
-0.043700
 | 
8.29e-01
 | 
| 
SPRY REGULATION OF FGF SIGNALING
 | 
16
 | 
7.62e-01
 | 
-0.043700
 | 
8.73e-01
 | 
| 
HS GAG DEGRADATION
 | 
19
 | 
7.44e-01
 | 
-0.043300
 | 
8.63e-01
 | 
| 
SEMAPHORIN INTERACTIONS
 | 
50
 | 
5.97e-01
 | 
-0.043200
 | 
7.74e-01
 | 
| 
FORMATION OF RNA POL II ELONGATION COMPLEX
 | 
51
 | 
5.95e-01
 | 
-0.043100
 | 
7.74e-01
 | 
| 
DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR
 | 
73
 | 
5.26e-01
 | 
-0.042900
 | 
7.20e-01
 | 
| 
UB SPECIFIC PROCESSING PROTEASES
 | 
151
 | 
3.64e-01
 | 
-0.042800
 | 
5.90e-01
 | 
| 
REGULATION OF CDH11 EXPRESSION AND FUNCTION
 | 
11
 | 
8.07e-01
 | 
0.042400
 | 
8.99e-01
 | 
| 
TRANSCRIPTIONAL REGULATION BY SMALL RNAS
 | 
32
 | 
6.79e-01
 | 
-0.042300
 | 
8.26e-01
 | 
| 
CLASS A 1 RHODOPSIN LIKE RECEPTORS
 | 
107
 | 
4.53e-01
 | 
0.042100
 | 
6.59e-01
 | 
| 
REGULATION OF RUNX2 EXPRESSION AND ACTIVITY
 | 
50
 | 
6.08e-01
 | 
0.042000
 | 
7.83e-01
 | 
| 
SIGNALING BY NTRKS
 | 
73
 | 
5.36e-01
 | 
-0.041900
 | 
7.30e-01
 | 
| 
THE ROLE OF GTSE1 IN G2 M PROGRESSION AFTER G2 CHECKPOINT
 | 
68
 | 
5.54e-01
 | 
-0.041500
 | 
7.41e-01
 | 
| 
CLEC7A DECTIN 1 SIGNALING
 | 
88
 | 
5.02e-01
 | 
-0.041500
 | 
7.04e-01
 | 
| 
TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION
 | 
164
 | 
3.68e-01
 | 
-0.040800
 | 
5.94e-01
 | 
| 
PROTEIN PROTEIN INTERACTIONS AT SYNAPSES
 | 
45
 | 
6.37e-01
 | 
0.040700
 | 
7.99e-01
 | 
| 
ACTIVATION OF THE AP 1 FAMILY OF TRANSCRIPTION FACTORS
 | 
10
 | 
8.29e-01
 | 
0.039500
 | 
9.09e-01
 | 
| 
RNA POLYMERASE II PRE TRANSCRIPTION EVENTS
 | 
72
 | 
5.64e-01
 | 
-0.039300
 | 
7.49e-01
 | 
| 
SIGNALING BY WNT
 | 
201
 | 
3.42e-01
 | 
-0.039000
 | 
5.64e-01
 | 
| 
NUCLEOTIDE SALVAGE
 | 
19
 | 
7.70e-01
 | 
-0.038700
 | 
8.74e-01
 | 
| 
GLYCOSPHINGOLIPID CATABOLISM
 | 
28
 | 
7.23e-01
 | 
0.038700
 | 
8.53e-01
 | 
| 
ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION
 | 
273
 | 
2.75e-01
 | 
0.038500
 | 
4.84e-01
 | 
| 
ROS AND RNS PRODUCTION IN PHAGOCYTES
 | 
29
 | 
7.23e-01
 | 
0.038000
 | 
8.53e-01
 | 
| 
IRAK2 MEDIATED ACTIVATION OF TAK1 COMPLEX
 | 
10
 | 
8.38e-01
 | 
-0.037300
 | 
9.12e-01
 | 
| 
OXIDATIVE STRESS INDUCED SENESCENCE
 | 
37
 | 
6.95e-01
 | 
-0.037300
 | 
8.37e-01
 | 
| 
GLUTAMATE AND GLUTAMINE METABOLISM
 | 
10
 | 
8.40e-01
 | 
0.036900
 | 
9.12e-01
 | 
| 
NEUROTRANSMITTER RECEPTORS AND POSTSYNAPTIC SIGNAL TRANSMISSION
 | 
89
 | 
5.48e-01
 | 
0.036900
 | 
7.38e-01
 | 
| 
DOWNSTREAM TCR SIGNALING
 | 
78
 | 
5.76e-01
 | 
-0.036700
 | 
7.60e-01
 | 
| 
PCP CE PATHWAY
 | 
82
 | 
5.73e-01
 | 
-0.036100
 | 
7.57e-01
 | 
| 
REGULATION OF TLR BY ENDOGENOUS LIGAND
 | 
15
 | 
8.10e-01
 | 
0.035900
 | 
9.00e-01
 | 
| 
BETA CATENIN PHOSPHORYLATION CASCADE
 | 
17
 | 
8.02e-01
 | 
0.035200
 | 
8.95e-01
 | 
| 
HEME SIGNALING
 | 
12
 | 
8.33e-01
 | 
-0.035100
 | 
9.12e-01
 | 
| 
GOLGI ASSOCIATED VESICLE BIOGENESIS
 | 
51
 | 
6.66e-01
 | 
-0.035000
 | 
8.16e-01
 | 
| 
FC EPSILON RECEPTOR FCERI SIGNALING
 | 
110
 | 
5.28e-01
 | 
-0.034900
 | 
7.21e-01
 | 
| 
BASIGIN INTERACTIONS
 | 
18
 | 
7.98e-01
 | 
-0.034900
 | 
8.93e-01
 | 
| 
TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS
 | 
13
 | 
8.29e-01
 | 
0.034600
 | 
9.09e-01
 | 
| 
TRANS GOLGI NETWORK VESICLE BUDDING
 | 
66
 | 
6.30e-01
 | 
0.034300
 | 
7.95e-01
 | 
| 
SIGNALING BY NTRK1 TRKA
 | 
62
 | 
6.42e-01
 | 
-0.034200
 | 
8.01e-01
 | 
| 
SIGNALING BY INSULIN RECEPTOR
 | 
56
 | 
6.61e-01
 | 
-0.033900
 | 
8.15e-01
 | 
| 
VESICLE MEDIATED TRANSPORT
 | 
522
 | 
1.90e-01
 | 
-0.033700
 | 
3.90e-01
 | 
| 
TP53 REGULATES TRANSCRIPTION OF DNA REPAIR GENES
 | 
40
 | 
7.16e-01
 | 
-0.033300
 | 
8.51e-01
 | 
| 
VLDLR INTERNALISATION AND DEGRADATION
 | 
15
 | 
8.24e-01
 | 
0.033300
 | 
9.07e-01
 | 
| 
INTERLEUKIN 2 FAMILY SIGNALING
 | 
26
 | 
7.71e-01
 | 
-0.032900
 | 
8.74e-01
 | 
| 
MAPK6 MAPK4 SIGNALING
 | 
70
 | 
6.35e-01
 | 
-0.032900
 | 
7.99e-01
 | 
| 
SNRNP ASSEMBLY
 | 
47
 | 
7.01e-01
 | 
0.032300
 | 
8.42e-01
 | 
| 
RNA POLYMERASE I TRANSCRIPTION TERMINATION
 | 
26
 | 
7.77e-01
 | 
-0.032100
 | 
8.78e-01
 | 
| 
REGULATION OF INSULIN SECRETION
 | 
49
 | 
6.98e-01
 | 
-0.032000
 | 
8.39e-01
 | 
| 
DEPOLYMERIZATION OF THE NUCLEAR LAMINA
 | 
11
 | 
8.54e-01
 | 
-0.032000
 | 
9.16e-01
 | 
| 
CELL CELL JUNCTION ORGANIZATION
 | 
37
 | 
7.36e-01
 | 
-0.032000
 | 
8.59e-01
 | 
| 
ADHERENS JUNCTIONS INTERACTIONS
 | 
29
 | 
7.70e-01
 | 
-0.031300
 | 
8.74e-01
 | 
| 
ACTIVATION OF APC C AND APC C CDC20 MEDIATED DEGRADATION OF MITOTIC PROTEINS
 | 
72
 | 
6.51e-01
 | 
-0.030900
 | 
8.09e-01
 | 
| 
FORMATION OF TC NER PRE INCISION COMPLEX
 | 
49
 | 
7.12e-01
 | 
0.030500
 | 
8.48e-01
 | 
| 
BUTYRATE RESPONSE FACTOR 1 BRF1 BINDS AND DESTABILIZES MRNA
 | 
16
 | 
8.41e-01
 | 
-0.029000
 | 
9.12e-01
 | 
| 
REGULATION OF HSF1 MEDIATED HEAT SHOCK RESPONSE
 | 
62
 | 
6.96e-01
 | 
0.028700
 | 
8.37e-01
 | 
| 
MAPK FAMILY SIGNALING CASCADES
 | 
258
 | 
4.28e-01
 | 
-0.028700
 | 
6.40e-01
 | 
| 
INACTIVATION OF CSF3 G CSF SIGNALING
 | 
15
 | 
8.49e-01
 | 
0.028500
 | 
9.16e-01
 | 
| 
SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI
 | 
17
 | 
8.41e-01
 | 
0.028100
 | 
9.12e-01
 | 
| 
HEDGEHOG OFF STATE
 | 
100
 | 
6.29e-01
 | 
-0.028000
 | 
7.95e-01
 | 
| 
SIGNALING BY NOTCH3
 | 
19
 | 
8.34e-01
 | 
0.027800
 | 
9.12e-01
 | 
| 
RMTS METHYLATE HISTONE ARGININES
 | 
25
 | 
8.10e-01
 | 
-0.027800
 | 
9.00e-01
 | 
| 
O GLYCOSYLATION OF TSR DOMAIN CONTAINING PROTEINS
 | 
34
 | 
7.80e-01
 | 
0.027700
 | 
8.78e-01
 | 
| 
MAPK TARGETS NUCLEAR EVENTS MEDIATED BY MAP KINASES
 | 
28
 | 
8.05e-01
 | 
0.027000
 | 
8.98e-01
 | 
| 
METABOLISM OF POLYAMINES
 | 
54
 | 
7.32e-01
 | 
0.026900
 | 
8.59e-01
 | 
| 
WNT LIGAND BIOGENESIS AND TRAFFICKING
 | 
13
 | 
8.70e-01
 | 
-0.026200
 | 
9.28e-01
 | 
| 
RUNX1 REGULATES TRANSCRIPTION OF GENES INVOLVED IN DIFFERENTIATION OF HSCS
 | 
61
 | 
7.27e-01
 | 
-0.025800
 | 
8.55e-01
 | 
| 
ACTIVATION OF NF KAPPAB IN B CELLS
 | 
59
 | 
7.38e-01
 | 
-0.025200
 | 
8.59e-01
 | 
| 
NITRIC OXIDE STIMULATES GUANYLATE CYCLASE
 | 
12
 | 
8.81e-01
 | 
0.024900
 | 
9.30e-01
 | 
| 
AUF1 HNRNP D0 BINDS AND DESTABILIZES MRNA
 | 
53
 | 
7.55e-01
 | 
0.024800
 | 
8.67e-01
 | 
| 
SEALING OF THE NUCLEAR ENVELOPE NE BY ESCRT III
 | 
23
 | 
8.38e-01
 | 
0.024600
 | 
9.12e-01
 | 
| 
KSRP KHSRP BINDS AND DESTABILIZES MRNA
 | 
14
 | 
8.75e-01
 | 
0.024300
 | 
9.29e-01
 | 
| 
SYNTHESIS OF PROSTAGLANDINS PG AND THROMBOXANES TX
 | 
11
 | 
8.89e-01
 | 
0.024200
 | 
9.35e-01
 | 
| 
PI3K EVENTS IN ERBB2 SIGNALING
 | 
13
 | 
8.80e-01
 | 
0.024200
 | 
9.30e-01
 | 
| 
PEXOPHAGY
 | 
10
 | 
8.96e-01
 | 
-0.023800
 | 
9.39e-01
 | 
| 
CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE
 | 
20
 | 
8.54e-01
 | 
0.023800
 | 
9.16e-01
 | 
| 
RHOH GTPASE CYCLE
 | 
31
 | 
8.20e-01
 | 
-0.023600
 | 
9.05e-01
 | 
| 
INSERTION OF TAIL ANCHORED PROTEINS INTO THE ENDOPLASMIC RETICULUM MEMBRANE
 | 
15
 | 
8.78e-01
 | 
0.022900
 | 
9.30e-01
 | 
| 
TCF DEPENDENT SIGNALING IN RESPONSE TO WNT
 | 
135
 | 
6.56e-01
 | 
-0.022200
 | 
8.12e-01
 | 
| 
INTEGRATION OF ENERGY METABOLISM
 | 
59
 | 
7.68e-01
 | 
-0.022200
 | 
8.74e-01
 | 
| 
REGULATION OF RUNX3 EXPRESSION AND ACTIVITY
 | 
53
 | 
7.87e-01
 | 
-0.021500
 | 
8.84e-01
 | 
| 
ADENYLATE CYCLASE ACTIVATING PATHWAY
 | 
10
 | 
9.07e-01
 | 
-0.021400
 | 
9.47e-01
 | 
| 
DEGRADATION OF BETA CATENIN BY THE DESTRUCTION COMPLEX
 | 
75
 | 
7.52e-01
 | 
0.021100
 | 
8.67e-01
 | 
| 
POST TRANSLATIONAL PROTEIN MODIFICATION
 | 
1089
 | 
2.60e-01
 | 
-0.020500
 | 
4.68e-01
 | 
| 
FCERI MEDIATED NF KB ACTIVATION
 | 
70
 | 
7.69e-01
 | 
0.020400
 | 
8.74e-01
 | 
| 
HSP90 CHAPERONE CYCLE FOR STEROID HORMONE RECEPTORS SHR IN THE PRESENCE OF LIGAND
 | 
46
 | 
8.13e-01
 | 
-0.020200
 | 
9.00e-01
 | 
| 
RAB REGULATION OF TRAFFICKING
 | 
109
 | 
7.18e-01
 | 
-0.020000
 | 
8.52e-01
 | 
| 
PEPTIDE LIGAND BINDING RECEPTORS
 | 
57
 | 
7.94e-01
 | 
0.020000
 | 
8.90e-01
 | 
| 
SIGNALING BY ERBB4
 | 
32
 | 
8.50e-01
 | 
0.019400
 | 
9.16e-01
 | 
| 
GROWTH HORMONE RECEPTOR SIGNALING
 | 
10
 | 
9.16e-01
 | 
0.019300
 | 
9.53e-01
 | 
| 
NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION
 | 
27
 | 
8.64e-01
 | 
0.019100
 | 
9.25e-01
 | 
| 
PURINE CATABOLISM
 | 
16
 | 
8.98e-01
 | 
0.018500
 | 
9.40e-01
 | 
| 
HEDGEHOG LIGAND BIOGENESIS
 | 
56
 | 
8.12e-01
 | 
-0.018400
 | 
9.00e-01
 | 
| 
UBIQUITIN MEDIATED DEGRADATION OF PHOSPHORYLATED CDC25A
 | 
49
 | 
8.24e-01
 | 
0.018400
 | 
9.07e-01
 | 
| 
ER TO GOLGI ANTEROGRADE TRANSPORT
 | 
139
 | 
7.09e-01
 | 
-0.018300
 | 
8.45e-01
 | 
| 
SIGNALLING TO RAS
 | 
12
 | 
9.15e-01
 | 
-0.017800
 | 
9.53e-01
 | 
| 
ASYMMETRIC LOCALIZATION OF PCP PROTEINS
 | 
59
 | 
8.15e-01
 | 
-0.017600
 | 
9.00e-01
 | 
| 
FORMATION OF INCISION COMPLEX IN GG NER
 | 
43
 | 
8.42e-01
 | 
-0.017500
 | 
9.12e-01
 | 
| 
EFFECTS OF PIP2 HYDROLYSIS
 | 
22
 | 
8.87e-01
 | 
-0.017500
 | 
9.35e-01
 | 
| 
PLASMA LIPOPROTEIN CLEARANCE
 | 
28
 | 
8.73e-01
 | 
0.017400
 | 
9.29e-01
 | 
| 
GENE SILENCING BY RNA
 | 
40
 | 
8.49e-01
 | 
-0.017400
 | 
9.16e-01
 | 
| 
DDX58 IFIH1 MEDIATED INDUCTION OF INTERFERON ALPHA BETA
 | 
31
 | 
8.68e-01
 | 
-0.017300
 | 
9.27e-01
 | 
| 
PTEN REGULATION
 | 
95
 | 
7.71e-01
 | 
0.017300
 | 
8.74e-01
 | 
| 
APC C CDC20 MEDIATED DEGRADATION OF CYCLIN B
 | 
23
 | 
8.88e-01
 | 
-0.017000
 | 
9.35e-01
 | 
| 
HEPARAN SULFATE HEPARIN HS GAG METABOLISM
 | 
41
 | 
8.53e-01
 | 
-0.016800
 | 
9.16e-01
 | 
| 
POST TRANSLATIONAL MODIFICATION SYNTHESIS OF GPI ANCHORED PROTEINS
 | 
54
 | 
8.37e-01
 | 
0.016200
 | 
9.12e-01
 | 
| 
TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES
 | 
30
 | 
8.80e-01
 | 
0.016000
 | 
9.30e-01
 | 
| 
GABA RECEPTOR ACTIVATION
 | 
37
 | 
8.71e-01
 | 
-0.015400
 | 
9.28e-01
 | 
| 
INTERLEUKIN 15 SIGNALING
 | 
10
 | 
9.35e-01
 | 
-0.014900
 | 
9.66e-01
 | 
| 
SENSORY PERCEPTION
 | 
56
 | 
8.54e-01
 | 
0.014300
 | 
9.16e-01
 | 
| 
G ALPHA I SIGNALLING EVENTS
 | 
129
 | 
7.80e-01
 | 
-0.014200
 | 
8.78e-01
 | 
| 
GLI3 IS PROCESSED TO GLI3R BY THE PROTEASOME
 | 
54
 | 
8.70e-01
 | 
0.012900
 | 
9.28e-01
 | 
| 
DNA DAMAGE RECOGNITION IN GG NER
 | 
38
 | 
8.92e-01
 | 
0.012800
 | 
9.36e-01
 | 
| 
NUCLEAR ENVELOPE NE REASSEMBLY
 | 
61
 | 
8.64e-01
 | 
-0.012700
 | 
9.25e-01
 | 
| 
REGULATION OF MRNA STABILITY BY PROTEINS THAT BIND AU RICH ELEMENTS
 | 
81
 | 
8.45e-01
 | 
-0.012600
 | 
9.14e-01
 | 
| 
INTERACTION BETWEEN L1 AND ANKYRINS
 | 
10
 | 
9.47e-01
 | 
-0.012200
 | 
9.70e-01
 | 
| 
DEGRADATION OF AXIN
 | 
52
 | 
8.79e-01
 | 
-0.012200
 | 
9.30e-01
 | 
| 
GPCR LIGAND BINDING
 | 
139
 | 
8.13e-01
 | 
-0.011700
 | 
9.00e-01
 | 
| 
COMMON PATHWAY OF FIBRIN CLOT FORMATION
 | 
12
 | 
9.45e-01
 | 
-0.011400
 | 
9.70e-01
 | 
| 
SIGNALING BY NUCLEAR RECEPTORS
 | 
144
 | 
8.14e-01
 | 
-0.011400
 | 
9.00e-01
 | 
| 
JOSEPHIN DOMAIN DUBS
 | 
10
 | 
9.51e-01
 | 
-0.011300
 | 
9.70e-01
 | 
| 
CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION
 | 
314
 | 
7.33e-01
 | 
-0.011200
 | 
8.59e-01
 | 
| 
TRANSPORT OF BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS
 | 
49
 | 
8.93e-01
 | 
-0.011100
 | 
9.36e-01
 | 
| 
REGULATION OF PTEN STABILITY AND ACTIVITY
 | 
66
 | 
8.78e-01
 | 
-0.010900
 | 
9.30e-01
 | 
| 
ESTROGEN DEPENDENT GENE EXPRESSION
 | 
43
 | 
9.12e-01
 | 
0.009730
 | 
9.51e-01
 | 
| 
METABOLISM OF FAT SOLUBLE VITAMINS
 | 
31
 | 
9.26e-01
 | 
-0.009680
 | 
9.61e-01
 | 
| 
POSTMITOTIC NUCLEAR PORE COMPLEX NPC REFORMATION
 | 
22
 | 
9.39e-01
 | 
-0.009500
 | 
9.68e-01
 | 
| 
THE PHOTOTRANSDUCTION CASCADE
 | 
17
 | 
9.47e-01
 | 
-0.009290
 | 
9.70e-01
 | 
| 
CARBOXYTERMINAL POST TRANSLATIONAL MODIFICATIONS OF TUBULIN
 | 
18
 | 
9.46e-01
 | 
-0.009170
 | 
9.70e-01
 | 
| 
EPH EPHRIN MEDIATED REPULSION OF CELLS
 | 
28
 | 
9.34e-01
 | 
-0.009060
 | 
9.66e-01
 | 
| 
CROSS PRESENTATION OF SOLUBLE EXOGENOUS ANTIGENS ENDOSOMES
 | 
45
 | 
9.20e-01
 | 
0.008680
 | 
9.56e-01
 | 
| 
METABOLISM OF CARBOHYDRATES
 | 
219
 | 
8.42e-01
 | 
0.007860
 | 
9.12e-01
 | 
| 
GABA B RECEPTOR ACTIVATION
 | 
33
 | 
9.38e-01
 | 
0.007860
 | 
9.68e-01
 | 
| 
ERK MAPK TARGETS
 | 
19
 | 
9.53e-01
 | 
0.007850
 | 
9.70e-01
 | 
| 
THE CANONICAL RETINOID CYCLE IN RODS TWILIGHT VISION
 | 
10
 | 
9.67e-01
 | 
0.007440
 | 
9.79e-01
 | 
| 
SIALIC ACID METABOLISM
 | 
25
 | 
9.50e-01
 | 
0.007320
 | 
9.70e-01
 | 
| 
VISUAL PHOTOTRANSDUCTION
 | 
51
 | 
9.30e-01
 | 
0.007160
 | 
9.63e-01
 | 
| 
DECTIN 1 MEDIATED NONCANONICAL NF KB SIGNALING
 | 
54
 | 
9.30e-01
 | 
0.006900
 | 
9.63e-01
 | 
| 
FORMATION OF WDR5 CONTAINING HISTONE MODIFYING COMPLEXES
 | 
36
 | 
9.44e-01
 | 
0.006770
 | 
9.70e-01
 | 
| 
RHO GTPASES ACTIVATE PKNS
 | 
21
 | 
9.58e-01
 | 
0.006620
 | 
9.72e-01
 | 
| 
DISASSEMBLY OF THE DESTRUCTION COMPLEX AND RECRUITMENT OF AXIN TO THE MEMBRANE
 | 
26
 | 
9.60e-01
 | 
-0.005740
 | 
9.73e-01
 | 
| 
NONHOMOLOGOUS END JOINING NHEJ
 | 
31
 | 
9.58e-01
 | 
0.005500
 | 
9.72e-01
 | 
| 
METABOLISM OF RNA
 | 
559
 | 
8.25e-01
 | 
-0.005500
 | 
9.07e-01
 | 
| 
STABILIZATION OF P53
 | 
52
 | 
9.48e-01
 | 
-0.005200
 | 
9.70e-01
 | 
| 
TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX WITHIN TLR4 COMPLEX
 | 
15
 | 
9.73e-01
 | 
0.004960
 | 
9.81e-01
 | 
| 
CYTOSOLIC SULFONATION OF SMALL MOLECULES
 | 
12
 | 
9.77e-01
 | 
0.004750
 | 
9.84e-01
 | 
| 
SIGNALING BY CSF3 G CSF
 | 
19
 | 
9.73e-01
 | 
0.004520
 | 
9.81e-01
 | 
| 
ASPARAGINE N LINKED GLYCOSYLATION
 | 
241
 | 
9.07e-01
 | 
0.004390
 | 
9.47e-01
 | 
| 
CDK MEDIATED PHOSPHORYLATION AND REMOVAL OF CDC6
 | 
69
 | 
9.50e-01
 | 
-0.004360
 | 
9.70e-01
 | 
| 
RAB GERANYLGERANYLATION
 | 
52
 | 
9.58e-01
 | 
-0.004270
 | 
9.72e-01
 | 
| 
APC C CDH1 MEDIATED DEGRADATION OF CDC20 AND OTHER APC C CDH1 TARGETED PROTEINS IN LATE MITOSIS EARLY G1
 | 
71
 | 
9.52e-01
 | 
0.004180
 | 
9.70e-01
 | 
| 
MISCELLANEOUS TRANSPORT AND BINDING EVENTS
 | 
18
 | 
9.80e-01
 | 
0.003460
 | 
9.85e-01
 | 
| 
PROTEIN UBIQUITINATION
 | 
56
 | 
9.73e-01
 | 
-0.002630
 | 
9.81e-01
 | 
| 
RNA POLYMERASE II TRANSCRIBES SNRNA GENES
 | 
68
 | 
9.71e-01
 | 
0.002560
 | 
9.81e-01
 | 
| 
TRANSPORT OF CONNEXONS TO THE PLASMA MEMBRANE
 | 
13
 | 
9.92e-01
 | 
0.001610
 | 
9.95e-01
 | 
| 
SPHINGOLIPID METABOLISM
 | 
72
 | 
9.83e-01
 | 
0.001480
 | 
9.87e-01
 | 
| 
IRAK1 RECRUITS IKK COMPLEX
 | 
14
 | 
9.93e-01
 | 
-0.001370
 | 
9.95e-01
 | 
| 
SUMOYLATION OF TRANSCRIPTION FACTORS
 | 
13
 | 
9.95e-01
 | 
0.001080
 | 
9.96e-01
 | 
| 
CARGO RECOGNITION FOR CLATHRIN MEDIATED ENDOCYTOSIS
 | 
82
 | 
9.98e-01
 | 
0.000127
 | 
9.98e-01
 |